Gene Symbol | Gene ID | Gene Info |
---|---|---|
Klf4
|
ENSMUSG00000003032.8 | Kruppel-like factor 4 (gut) |
Sp3
|
ENSMUSG00000027109.10 | trans-acting transcription factor 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr4_55532892_55533335 | Klf4 | 647 | 0.676390 | -0.55 | 1.3e-05 | Click! |
chr4_55526526_55526677 | Klf4 | 5169 | 0.175033 | -0.48 | 2.5e-04 | Click! |
chr4_55531336_55531735 | Klf4 | 235 | 0.916196 | -0.45 | 5.7e-04 | Click! |
chr4_55532729_55532885 | Klf4 | 341 | 0.861676 | -0.44 | 7.0e-04 | Click! |
chr4_55530574_55530971 | Klf4 | 998 | 0.501016 | -0.44 | 8.2e-04 | Click! |
chr2_72975841_72976127 | Sp3 | 3302 | 0.171313 | 0.67 | 2.7e-08 | Click! |
chr2_72978962_72979321 | Sp3 | 145 | 0.674806 | 0.66 | 3.4e-08 | Click! |
chr2_72913506_72913657 | Sp3 | 27503 | 0.142546 | -0.65 | 5.8e-08 | Click! |
chr2_72908187_72908356 | Sp3 | 32813 | 0.135708 | 0.62 | 3.9e-07 | Click! |
chr2_72889510_72889661 | Sp3 | 51499 | 0.107544 | 0.56 | 7.3e-06 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr6_125095392_125097556 | 223.92 |
Chd4 |
chromodomain helicase DNA binding protein 4 |
95 |
0.84 |
chr2_170130477_170131578 | 216.97 |
Zfp217 |
zinc finger protein 217 |
193 |
0.97 |
chr10_80576603_80578409 | 209.76 |
Klf16 |
Kruppel-like factor 16 |
185 |
0.86 |
chr2_153492229_153493481 | 208.27 |
4930404H24Rik |
RIKEN cDNA 4930404H24 gene |
65 |
0.82 |
chr5_109557850_109558797 | 196.90 |
Crlf2 |
cytokine receptor-like factor 2 |
613 |
0.67 |
chr4_140701770_140702866 | 174.10 |
Rcc2 |
regulator of chromosome condensation 2 |
845 |
0.47 |
chr10_120216764_120217346 | 169.65 |
Tmbim4 |
transmembrane BAX inhibitor motif containing 4 |
3633 |
0.18 |
chr17_34898151_34899707 | 161.43 |
Ehmt2 |
euchromatic histone lysine N-methyltransferase 2 |
25 |
0.87 |
chr14_20793233_20794132 | 159.91 |
Camk2g |
calcium/calmodulin-dependent protein kinase II gamma |
284 |
0.68 |
chr8_70698268_70700333 | 157.48 |
Jund |
jun D proto-oncogene |
351 |
0.45 |
chr2_174329445_174331091 | 156.55 |
Gnas |
GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus |
19 |
0.97 |
chrY_90771840_90772811 | 153.27 |
Gm47283 |
predicted gene, 47283 |
12413 |
0.17 |
chr3_51340298_51341882 | 152.65 |
Elf2 |
E74-like factor 2 |
427 |
0.74 |
chr11_74837693_74838808 | 148.91 |
Mnt |
max binding protein |
782 |
0.52 |
chr7_127768560_127769629 | 143.00 |
Orai3 |
ORAI calcium release-activated calcium modulator 3 |
721 |
0.4 |
chr5_137530580_137532081 | 140.34 |
Gnb2 |
guanine nucleotide binding protein (G protein), beta 2 |
33 |
0.9 |
chrX_142680720_142682167 | 139.30 |
Tmem164 |
transmembrane protein 164 |
25 |
0.98 |
chr10_69910043_69910940 | 138.97 |
Ank3 |
ankyrin 3, epithelial |
4374 |
0.35 |
chrX_169997850_169998483 | 137.45 |
Gm15247 |
predicted gene 15247 |
11227 |
0.14 |
chr11_70021148_70021981 | 135.20 |
Dlg4 |
discs large MAGUK scaffold protein 4 |
2356 |
0.11 |
chr11_98741567_98742727 | 132.10 |
Thra |
thyroid hormone receptor alpha |
11 |
0.95 |
chr14_115040506_115042372 | 131.09 |
Mir17hg |
Mir17 host gene (non-protein coding) |
1440 |
0.19 |
chr8_70538591_70539987 | 128.10 |
Ell |
elongation factor RNA polymerase II |
168 |
0.88 |
chr10_127508848_127510720 | 127.77 |
Stac3 |
SH3 and cysteine rich domain 3 |
2559 |
0.15 |
chr15_58140746_58142050 | 127.33 |
Wdyhv1 |
WDYHV motif containing 1 |
6 |
0.96 |
chr15_98608664_98610204 | 123.14 |
Adcy6 |
adenylate cyclase 6 |
598 |
0.55 |
chr11_69996486_69997590 | 122.95 |
Phf23 |
PHD finger protein 23 |
47 |
0.91 |
chr14_14347096_14348750 | 121.16 |
Gm48860 |
predicted gene, 48860 |
659 |
0.44 |
chr14_25606696_25608421 | 121.07 |
Zmiz1 |
zinc finger, MIZ-type containing 1 |
201 |
0.95 |
chr8_120486990_120488549 | 120.74 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
678 |
0.64 |
chr9_109094576_109096217 | 119.42 |
Plxnb1 |
plexin B1 |
7 |
0.95 |
chr7_127026546_127028177 | 117.92 |
Maz |
MYC-associated zinc finger protein (purine-binding transcription factor) |
324 |
0.58 |
chr2_75703696_75705127 | 117.79 |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
78 |
0.81 |
chr5_140439026_140439687 | 115.39 |
Eif3b |
eukaryotic translation initiation factor 3, subunit B |
586 |
0.63 |
chr5_144357735_144358915 | 112.44 |
Dmrt1i |
Dmrt1 interacting ncRNA |
200 |
0.51 |
chr10_79779826_79781202 | 112.39 |
Fstl3 |
follistatin-like 3 |
67 |
0.92 |
chr11_100938783_100940230 | 112.16 |
Stat3 |
signal transducer and activator of transcription 3 |
27 |
0.97 |
chr9_65826224_65827697 | 112.01 |
Zfp609 |
zinc finger protein 609 |
604 |
0.65 |
chr5_137786077_137787112 | 110.97 |
Mepce |
methylphosphate capping enzyme |
69 |
0.92 |
chr10_121475538_121476618 | 109.83 |
Rassf3 |
Ras association (RalGDS/AF-6) domain family member 3 |
269 |
0.86 |
chr14_55824498_55825973 | 109.56 |
Nfatc4 |
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 4 |
198 |
0.87 |
chr15_100747217_100747460 | 109.34 |
Slc4a8 |
solute carrier family 4 (anion exchanger), member 8 |
14409 |
0.11 |
chr11_117838543_117838973 | 108.12 |
Afmid |
arylformamidase |
6485 |
0.09 |
chr11_74896307_74898160 | 107.61 |
Sgsm2 |
small G protein signaling modulator 2 |
173 |
0.84 |
chr4_107253005_107253839 | 107.25 |
Lrrc42 |
leucine rich repeat containing 42 |
110 |
0.58 |
chr2_25982690_25983958 | 105.97 |
Camsap1 |
calmodulin regulated spectrin-associated protein 1 |
42 |
0.97 |
chr9_59577641_59578825 | 105.50 |
Celf6 |
CUGBP, Elav-like family member 6 |
41 |
0.97 |
chr7_28179836_28180482 | 103.94 |
Dyrk1b |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1b |
107 |
0.93 |
chr10_128525093_128526268 | 103.47 |
Esyt1 |
extended synaptotagmin-like protein 1 |
188 |
0.63 |
chr14_14354416_14355184 | 103.01 |
Il3ra |
interleukin 3 receptor, alpha chain |
5179 |
0.12 |
chr6_49367200_49368123 | 102.70 |
Fam221a |
family with sequence similarity 221, member A |
78 |
0.97 |
chr11_117968531_117970182 | 102.07 |
Socs3 |
suppressor of cytokine signaling 3 |
95 |
0.96 |
chr17_47923769_47925323 | 101.48 |
Foxp4 |
forkhead box P4 |
70 |
0.96 |
chr6_83456116_83457458 | 101.35 |
Tet3 |
tet methylcytosine dioxygenase 3 |
395 |
0.77 |
chr5_134688076_134689277 | 100.64 |
Limk1 |
LIM-domain containing, protein kinase |
78 |
0.96 |
chr10_80538778_80539361 | 99.09 |
Atp8b3 |
ATPase, class I, type 8B, member 3 |
21 |
0.95 |
chr14_40966316_40967615 | 99.07 |
Tspan14 |
tetraspanin 14 |
158 |
0.96 |
chr10_69908447_69908713 | 97.92 |
Ank3 |
ankyrin 3, epithelial |
6285 |
0.32 |
chr13_58006958_58007325 | 97.43 |
Mir874 |
microRNA 874 |
16059 |
0.21 |
chr4_156197393_156197799 | 97.05 |
Agrn |
agrin |
108 |
0.92 |
chr9_61370339_61371660 | 95.45 |
Gm10655 |
predicted gene 10655 |
628 |
0.63 |
chr8_107030704_107031406 | 94.75 |
Gm16208 |
predicted gene 16208 |
133 |
0.53 |
chrX_51204673_51205680 | 93.28 |
Mbnl3 |
muscleblind like splicing factor 3 |
656 |
0.65 |
chr11_69837611_69838644 | 93.26 |
Nlgn2 |
neuroligin 2 |
343 |
0.43 |
chr2_153528510_153529333 | 92.61 |
Nol4l |
nucleolar protein 4-like |
1050 |
0.54 |
chr19_4282702_4283651 | 92.44 |
Ankrd13d |
ankyrin repeat domain 13 family, member D |
39 |
0.93 |
chr18_24259035_24259422 | 91.99 |
Gm7701 |
predicted gene 7701 |
1850 |
0.37 |
chr5_111239248_111239612 | 91.95 |
Ttc28 |
tetratricopeptide repeat domain 28 |
4115 |
0.24 |
chr9_21917486_21918482 | 91.86 |
Rab3d |
RAB3D, member RAS oncogene family |
105 |
0.93 |
chr4_45530265_45531442 | 91.77 |
Shb |
src homology 2 domain-containing transforming protein B |
523 |
0.73 |
chr11_74831594_74833056 | 91.58 |
Mnt |
max binding protein |
1405 |
0.31 |
chr10_127667525_127668413 | 90.04 |
Nab2 |
Ngfi-A binding protein 2 |
599 |
0.4 |
chr4_134081752_134082448 | 89.81 |
Crybg2 |
crystallin beta-gamma domain containing 2 |
212 |
0.88 |
chr3_100488535_100489982 | 89.75 |
Tent5c |
terminal nucleotidyltransferase 5C |
60 |
0.85 |
chr16_93711386_93712056 | 89.50 |
Dop1b |
DOP1 leucine zipper like protein B |
183 |
0.93 |
chr3_85887352_85888077 | 89.20 |
4933425M03Rik |
RIKEN cDNA 4933425M03 gene |
23 |
0.56 |
chr15_79690079_79691459 | 89.20 |
Gtpbp1 |
GTP binding protein 1 |
76 |
0.92 |
chr14_69321815_69322332 | 89.10 |
Gm16677 |
predicted gene, 16677 |
15009 |
0.09 |
chr6_124919273_124920636 | 89.09 |
Ptms |
parathymosin |
149 |
0.88 |
chr14_69540059_69540582 | 89.07 |
Gm27174 |
predicted gene 27174 |
15012 |
0.09 |
chr2_154569188_154570416 | 88.41 |
E2f1 |
E2F transcription factor 1 |
82 |
0.95 |
chr14_70074487_70075571 | 87.42 |
Egr3 |
early growth response 3 |
2174 |
0.25 |
chr5_124862398_124863348 | 87.23 |
Zfp664 |
zinc finger protein 664 |
109 |
0.84 |
chr9_59750348_59751247 | 86.79 |
Senp8 |
SUMO/sentrin specific peptidase 8 |
87 |
0.51 |
chr7_45784749_45786509 | 86.77 |
Lmtk3 |
lemur tyrosine kinase 3 |
119 |
0.87 |
chr7_16781038_16782438 | 85.52 |
Slc1a5 |
solute carrier family 1 (neutral amino acid transporter), member 5 |
370 |
0.78 |
chr7_36697059_36698174 | 85.34 |
Tshz3 |
teashirt zinc finger family member 3 |
502 |
0.7 |
chr11_105589210_105590456 | 85.15 |
Tanc2 |
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 |
153 |
0.96 |
chr5_137349031_137350198 | 84.99 |
Ephb4 |
Eph receptor B4 |
495 |
0.62 |
chr4_149425818_149427108 | 84.98 |
Ube4b |
ubiquitination factor E4B |
137 |
0.94 |
chr7_30534433_30535339 | 84.72 |
Arhgap33 |
Rho GTPase activating protein 33 |
111 |
0.87 |
chr7_25249061_25250506 | 84.69 |
Erf |
Ets2 repressor factor |
947 |
0.33 |
chr11_80779330_80780330 | 84.51 |
Myo1d |
myosin ID |
173 |
0.95 |
chr5_36581343_36582156 | 84.49 |
Tbc1d14 |
TBC1 domain family, member 14 |
43 |
0.97 |
chr8_90907824_90909226 | 84.35 |
Chd9 |
chromodomain helicase DNA binding protein 9 |
89 |
0.52 |
chr17_47909349_47909983 | 84.12 |
Gm15556 |
predicted gene 15556 |
12712 |
0.13 |
chr5_134551282_134552920 | 83.86 |
Gm42884 |
predicted gene 42884 |
44 |
0.81 |
chr5_144255011_144256245 | 83.79 |
Bri3 |
brain protein I3 |
394 |
0.56 |
chr7_25689001_25689947 | 83.40 |
Tgfb1 |
transforming growth factor, beta 1 |
547 |
0.58 |
chr17_30004516_30005139 | 83.39 |
Zfand3 |
zinc finger, AN1-type domain 3 |
94 |
0.55 |
chr6_90988622_90989360 | 83.29 |
Iqsec1 |
IQ motif and Sec7 domain 1 |
306 |
0.9 |
chr1_166002288_166003185 | 83.25 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
58 |
0.72 |
chr7_100492773_100493523 | 83.24 |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
189 |
0.88 |
chr5_140829777_140830873 | 83.16 |
Gna12 |
guanine nucleotide binding protein, alpha 12 |
106 |
0.97 |
chr8_70791948_70793334 | 82.99 |
Mast3 |
microtubule associated serine/threonine kinase 3 |
204 |
0.83 |
chr2_106692893_106694599 | 82.63 |
Mpped2 |
metallophosphoesterase domain containing 2 |
477 |
0.85 |
chr19_41482494_41483686 | 82.62 |
Lcor |
ligand dependent nuclear receptor corepressor |
61 |
0.98 |
chr5_22344110_22345571 | 81.83 |
Reln |
reelin |
138 |
0.95 |
chr17_47694297_47695658 | 81.81 |
Frs3 |
fibroblast growth factor receptor substrate 3 |
221 |
0.44 |
chr4_152086414_152087408 | 81.79 |
Plekhg5 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
53 |
0.96 |
chr11_105125823_105126961 | 81.60 |
Mettl2 |
methyltransferase like 2 |
33 |
0.97 |
chr8_120276000_120276974 | 81.59 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
48031 |
0.12 |
chr12_24651648_24652438 | 81.29 |
Klf11 |
Kruppel-like factor 11 |
111 |
0.96 |
chr11_116624141_116624473 | 81.06 |
Rhbdf2 |
rhomboid 5 homolog 2 |
60 |
0.95 |
chr10_61534398_61535221 | 80.92 |
Gm17829 |
predicted gene, 17829 |
24224 |
0.1 |
chr17_27826103_27826412 | 80.68 |
Ilrun |
inflammation and lipid regulator with UBA-like and NBR1-like domains |
5609 |
0.13 |
chrX_48284788_48285532 | 80.65 |
Gm22528 |
predicted gene, 22528 |
14419 |
0.13 |
chr2_156720289_156721547 | 80.47 |
4930405A21Rik |
RIKEN cDNA 4930405A21 gene |
9 |
0.6 |
chr12_8770800_8772245 | 80.22 |
Sdc1 |
syndecan 1 |
109 |
0.78 |
chr9_50856310_50857724 | 80.14 |
Ppp2r1b |
protein phosphatase 2, regulatory subunit A, beta |
38 |
0.97 |
chr6_72097140_72098281 | 79.56 |
St3gal5 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 5 |
47 |
0.96 |
chr2_48949106_48950119 | 79.39 |
Mbd5 |
methyl-CpG binding domain protein 5 |
89 |
0.8 |
chr10_93666253_93666601 | 79.24 |
Gm8580 |
predicted gene 8580 |
581 |
0.67 |
chr19_6969291_6970359 | 79.23 |
Plcb3 |
phospholipase C, beta 3 |
11 |
0.93 |
chr16_44357986_44358161 | 79.01 |
Spice1 |
spindle and centriole associated protein 1 |
9578 |
0.2 |
chr2_143915149_143916129 | 78.79 |
Dstn |
destrin |
319 |
0.87 |
chr19_43493324_43493679 | 78.01 |
Cnnm1 |
cyclin M1 |
15 |
0.97 |
chr11_77607040_77608322 | 77.72 |
Taok1 |
TAO kinase 1 |
134 |
0.94 |
chr11_117114876_117115708 | 77.15 |
Sec14l1 |
SEC14-like lipid binding 1 |
40 |
0.96 |
chr5_129941152_129942065 | 76.89 |
Vkorc1l1 |
vitamin K epoxide reductase complex, subunit 1-like 1 |
362 |
0.76 |
chr11_98766610_98767640 | 76.70 |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
3301 |
0.13 |
chr11_98941353_98942362 | 76.46 |
Rara |
retinoic acid receptor, alpha |
2145 |
0.18 |
chr4_83623239_83623556 | 75.92 |
Gm27046 |
predicted gene, 27046 |
26094 |
0.17 |
chr15_36792317_36793249 | 75.80 |
Ywhaz |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide |
369 |
0.84 |
chr13_37825583_37827437 | 75.50 |
Rreb1 |
ras responsive element binding protein 1 |
195 |
0.94 |
chr11_117792296_117792500 | 75.27 |
Gm11724 |
predicted gene 11724 |
1085 |
0.24 |
chr4_149954471_149955779 | 75.26 |
Spsb1 |
splA/ryanodine receptor domain and SOCS box containing 1 |
82 |
0.97 |
chr3_88532663_88533971 | 74.56 |
Mex3a |
mex3 RNA binding family member A |
922 |
0.31 |
chr11_11684707_11686418 | 74.52 |
Gm11999 |
predicted gene 11999 |
162 |
0.73 |
chr1_86525613_86527056 | 74.44 |
Ptma |
prothymosin alpha |
392 |
0.81 |
chr8_84979246_84980613 | 74.42 |
Junb |
jun B proto-oncogene |
1211 |
0.19 |
chr4_88032518_88033581 | 74.33 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
232 |
0.71 |
chr7_141215165_141215936 | 74.28 |
Rassf7 |
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7 |
310 |
0.71 |
chr6_120665862_120666733 | 74.23 |
Cecr2 |
CECR2, histone acetyl-lysine reader |
72 |
0.98 |
chr11_116077910_116078580 | 74.01 |
Unc13d |
unc-13 homolog D |
284 |
0.82 |
chr7_48880950_48881793 | 73.98 |
Gm2788 |
predicted gene 2788 |
71 |
0.71 |
chr5_113164821_113165497 | 73.69 |
Gm43094 |
predicted gene 43094 |
1075 |
0.34 |
chr12_12941527_12942979 | 73.67 |
Mycn |
v-myc avian myelocytomatosis viral related oncogene, neuroblastoma derived |
339 |
0.83 |
chr3_65658208_65659857 | 73.49 |
Mir8120 |
microRNA 8120 |
256 |
0.89 |
chr7_16874715_16875380 | 73.27 |
9330104G04Rik |
RIKEN cDNA 9330104G04 gene |
161 |
0.62 |
chr8_104395019_104396337 | 72.89 |
Cmtm4 |
CKLF-like MARVEL transmembrane domain containing 4 |
129 |
0.93 |
chr17_70850487_70852089 | 72.89 |
Tgif1 |
TGFB-induced factor homeobox 1 |
81 |
0.94 |
chr9_106821518_106822739 | 72.72 |
Dcaf1 |
DDB1 and CUL4 associated factor 1 |
254 |
0.89 |
chr15_98933816_98934775 | 72.67 |
Gm41396 |
predicted gene, 41396 |
30 |
0.62 |
chr3_144720129_144720738 | 72.00 |
Sh3glb1 |
SH3-domain GRB2-like B1 (endophilin) |
98 |
0.95 |
chr5_140034121_140034770 | 71.99 |
Gm43702 |
predicted gene 43702 |
2269 |
0.28 |
chr12_101028530_101029714 | 71.96 |
Ccdc88c |
coiled-coil domain containing 88C |
66 |
0.95 |
chr5_139736302_139736636 | 71.88 |
Micall2 |
MICAL-like 2 |
133 |
0.95 |
chr4_154025644_154026533 | 71.79 |
Smim1 |
small integral membrane protein 1 |
51 |
0.95 |
chr4_129188973_129189769 | 71.70 |
S100pbp |
S100P binding protein |
127 |
0.78 |
chr4_129513695_129514851 | 71.67 |
Marcksl1 |
MARCKS-like 1 |
692 |
0.46 |
chr4_154882060_154882342 | 71.65 |
Mmel1 |
membrane metallo-endopeptidase-like 1 |
8 |
0.97 |
chr7_45017042_45018019 | 71.47 |
Rras |
related RAS viral (r-ras) oncogene |
431 |
0.52 |
chr7_16285532_16286609 | 71.45 |
Ccdc9 |
coiled-coil domain containing 9 |
45 |
0.95 |
chr9_57644752_57646108 | 71.25 |
Csk |
c-src tyrosine kinase |
187 |
0.91 |
chr8_70819994_70820875 | 71.12 |
Il12rb1 |
interleukin 12 receptor, beta 1 |
7218 |
0.07 |
chr17_28809053_28809624 | 70.88 |
Brpf3 |
bromodomain and PHD finger containing, 3 |
321 |
0.81 |
chr9_44498071_44499796 | 70.87 |
Bcl9l |
B cell CLL/lymphoma 9-like |
203 |
0.84 |
chr17_88065293_88066116 | 70.86 |
Fbxo11 |
F-box protein 11 |
413 |
0.86 |
chr6_97204968_97206158 | 70.85 |
Uba3 |
ubiquitin-like modifier activating enzyme 3 |
2 |
0.97 |
chr11_113651275_113651628 | 70.85 |
Slc39a11 |
solute carrier family 39 (metal ion transporter), member 11 |
1372 |
0.29 |
chr10_127062800_127064205 | 70.76 |
Cdk4 |
cyclin-dependent kinase 4 |
32 |
0.93 |
chr5_115506441_115507217 | 70.51 |
Pxn |
paxillin |
21 |
0.94 |
chr14_62760761_62761843 | 70.40 |
Ints6 |
integrator complex subunit 6 |
133 |
0.95 |
chr9_106367425_106368835 | 70.40 |
Dusp7 |
dual specificity phosphatase 7 |
502 |
0.7 |
chr11_75651168_75652336 | 70.10 |
Myo1c |
myosin IC |
242 |
0.88 |
chr3_144198270_144199266 | 70.08 |
Gm43445 |
predicted gene 43445 |
494 |
0.79 |
chr7_27258127_27259252 | 69.94 |
Numbl |
numb-like |
36 |
0.91 |
chr18_67288589_67289806 | 69.85 |
Impa2 |
inositol (myo)-1(or 4)-monophosphatase 2 |
11 |
0.97 |
chr11_12036502_12038049 | 69.62 |
Grb10 |
growth factor receptor bound protein 10 |
126 |
0.97 |
chr16_30063252_30064537 | 69.54 |
Hes1 |
hes family bHLH transcription factor 1 |
490 |
0.76 |
chr5_96162084_96163134 | 69.19 |
Cnot6l |
CCR4-NOT transcription complex, subunit 6-like |
619 |
0.75 |
chr17_47535748_47536285 | 69.02 |
Ccnd3 |
cyclin D3 |
30775 |
0.1 |
chr7_83891433_83892352 | 69.02 |
Mesd |
mesoderm development LRP chaperone |
108 |
0.78 |
chr11_85139345_85140659 | 68.94 |
Usp32 |
ubiquitin specific peptidase 32 |
34 |
0.97 |
chr4_32982786_32983988 | 68.78 |
Rragd |
Ras-related GTP binding D |
67 |
0.96 |
chr15_38078009_38079076 | 68.45 |
Ubr5 |
ubiquitin protein ligase E3 component n-recognin 5 |
117 |
0.87 |
chr3_88492417_88493241 | 68.42 |
Lmna |
lamin A |
483 |
0.61 |
chr11_69366461_69367262 | 68.11 |
Chd3 |
chromodomain helicase DNA binding protein 3 |
2082 |
0.14 |
chrX_36988645_36990253 | 67.71 |
Septin6 |
septin 6 |
42 |
0.97 |
chr17_32389112_32389653 | 67.38 |
Wiz |
widely-interspaced zinc finger motifs |
6 |
0.84 |
chr5_140647773_140649317 | 67.23 |
Ttyh3 |
tweety family member 3 |
452 |
0.77 |
chr2_121289033_121290183 | 66.40 |
Map1a |
microtubule-associated protein 1 A |
8 |
0.96 |
chr2_93461958_93462733 | 65.94 |
Cd82 |
CD82 antigen |
41 |
0.97 |
chr2_165326390_165327162 | 65.82 |
Elmo2 |
engulfment and cell motility 2 |
297 |
0.87 |
chr7_28597227_28598470 | 65.77 |
Pak4 |
p21 (RAC1) activated kinase 4 |
238 |
0.53 |
chr8_11008854_11009914 | 65.72 |
Irs2 |
insulin receptor substrate 2 |
926 |
0.42 |
chr14_75130478_75131409 | 65.69 |
Lrrc63 |
leucine rich repeat containing 63 |
62 |
0.63 |
chr2_118662761_118664171 | 65.25 |
Pak6 |
p21 (RAC1) activated kinase 6 |
163 |
0.94 |
chr7_29210966_29212124 | 65.22 |
Catsperg1 |
cation channel sperm associated auxiliary subunit gamma 1 |
50 |
0.94 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
69.9 | 209.7 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
67.9 | 203.6 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
67.3 | 134.6 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
64.5 | 257.8 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
59.8 | 179.5 | GO:0008050 | female courtship behavior(GO:0008050) |
59.5 | 238.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
58.3 | 58.3 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) positive regulation of histone H4 acetylation(GO:0090240) |
56.0 | 168.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
55.1 | 165.4 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
54.8 | 164.3 | GO:0036166 | phenotypic switching(GO:0036166) |
53.0 | 159.1 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
49.5 | 148.5 | GO:0002432 | granuloma formation(GO:0002432) |
48.9 | 244.3 | GO:0072553 | terminal button organization(GO:0072553) |
47.7 | 143.0 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
46.6 | 139.7 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
46.4 | 92.8 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
46.2 | 277.1 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
45.5 | 91.1 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
44.2 | 132.7 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
44.2 | 132.7 | GO:0040031 | snRNA modification(GO:0040031) |
43.6 | 87.3 | GO:0071733 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
43.2 | 129.5 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
42.8 | 171.4 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
41.1 | 123.3 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
40.8 | 163.1 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
40.5 | 121.5 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
40.4 | 40.4 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
40.4 | 201.8 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
40.1 | 80.3 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
39.7 | 119.0 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
39.4 | 118.2 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
39.1 | 117.3 | GO:0007525 | somatic muscle development(GO:0007525) |
39.0 | 39.0 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
39.0 | 39.0 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
38.7 | 77.4 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
38.4 | 153.6 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
38.1 | 152.5 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
38.0 | 190.0 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
37.9 | 189.3 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
37.0 | 74.0 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
36.4 | 72.8 | GO:0050904 | diapedesis(GO:0050904) |
36.3 | 217.7 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
35.8 | 179.0 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
35.4 | 141.7 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
35.0 | 140.0 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
34.6 | 138.6 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
34.4 | 68.9 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
33.9 | 33.9 | GO:0048769 | sarcomerogenesis(GO:0048769) |
33.9 | 33.9 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
33.8 | 135.1 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
33.5 | 100.6 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
33.5 | 134.1 | GO:0023021 | termination of signal transduction(GO:0023021) |
33.5 | 67.0 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
33.3 | 100.0 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
32.9 | 65.9 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
32.9 | 32.9 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
32.3 | 129.0 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
32.2 | 96.6 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
32.0 | 128.0 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
31.7 | 95.2 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
31.6 | 126.2 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
31.5 | 125.9 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
31.4 | 125.6 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
31.4 | 125.4 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
31.1 | 155.3 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
31.1 | 93.2 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
31.0 | 93.1 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
31.0 | 92.9 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
31.0 | 31.0 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
30.9 | 154.4 | GO:0070627 | ferrous iron import(GO:0070627) |
30.8 | 123.3 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
30.8 | 184.7 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
30.7 | 30.7 | GO:0046822 | regulation of nucleocytoplasmic transport(GO:0046822) |
30.5 | 91.5 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
30.5 | 121.9 | GO:0007296 | vitellogenesis(GO:0007296) |
30.0 | 60.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
29.7 | 89.1 | GO:1902075 | cellular response to salt(GO:1902075) |
29.6 | 88.9 | GO:0015793 | glycerol transport(GO:0015793) |
29.6 | 118.4 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
29.6 | 88.7 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
29.5 | 117.8 | GO:0090168 | Golgi reassembly(GO:0090168) |
29.4 | 117.8 | GO:0043622 | cortical microtubule organization(GO:0043622) |
29.4 | 88.1 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
29.3 | 88.0 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
29.0 | 406.3 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
29.0 | 115.9 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
28.7 | 86.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
28.6 | 57.2 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
28.2 | 56.4 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
28.2 | 56.3 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
28.1 | 196.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
28.0 | 139.9 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
27.8 | 167.0 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
27.8 | 55.6 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
27.8 | 83.3 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
27.7 | 27.7 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
27.7 | 138.4 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
27.6 | 55.2 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
27.3 | 136.7 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
27.3 | 136.7 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
27.1 | 27.1 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
27.0 | 81.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
27.0 | 215.8 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
26.9 | 134.7 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
26.9 | 80.8 | GO:0000087 | mitotic M phase(GO:0000087) |
26.9 | 80.6 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
26.8 | 134.1 | GO:1903276 | regulation of sodium ion export(GO:1903273) regulation of sodium ion export from cell(GO:1903276) |
26.8 | 26.8 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
26.7 | 106.7 | GO:0009757 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
26.6 | 239.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
26.4 | 105.7 | GO:0070836 | caveola assembly(GO:0070836) |
26.4 | 131.9 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
26.3 | 52.7 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
26.2 | 78.5 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
26.0 | 130.2 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
26.0 | 26.0 | GO:0002159 | desmosome assembly(GO:0002159) |
26.0 | 26.0 | GO:0032808 | lacrimal gland development(GO:0032808) |
25.9 | 51.8 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
25.8 | 77.3 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
25.8 | 77.3 | GO:0097167 | circadian regulation of translation(GO:0097167) |
25.6 | 51.2 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
25.5 | 76.6 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
25.5 | 76.5 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
25.5 | 50.9 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
25.4 | 127.0 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
25.3 | 25.3 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
25.2 | 126.0 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
25.2 | 50.3 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
25.1 | 50.2 | GO:0018992 | germ-line sex determination(GO:0018992) |
25.1 | 301.3 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
25.1 | 100.3 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
25.0 | 75.0 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
24.9 | 99.6 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
24.9 | 99.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
24.9 | 24.9 | GO:0030071 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
24.8 | 74.4 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
24.8 | 99.2 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
24.8 | 49.5 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
24.7 | 148.3 | GO:0046060 | dATP metabolic process(GO:0046060) |
24.6 | 172.5 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
24.6 | 123.1 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
24.6 | 24.6 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
24.6 | 73.7 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
24.5 | 24.5 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
24.5 | 73.5 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
24.5 | 73.4 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
24.4 | 97.6 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
24.3 | 219.0 | GO:0034063 | stress granule assembly(GO:0034063) |
24.2 | 96.9 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
24.1 | 72.4 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
24.0 | 24.0 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
24.0 | 72.0 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
23.8 | 71.3 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
23.8 | 95.1 | GO:0003091 | renal water homeostasis(GO:0003091) |
23.8 | 118.9 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
23.7 | 71.2 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
23.7 | 23.7 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
23.7 | 71.0 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
23.6 | 94.4 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
23.6 | 47.1 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
23.5 | 70.6 | GO:0046208 | spermine catabolic process(GO:0046208) |
23.5 | 47.0 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
23.5 | 211.1 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
23.4 | 23.4 | GO:0032776 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
23.3 | 23.3 | GO:0010324 | membrane invagination(GO:0010324) |
23.3 | 162.9 | GO:0001842 | neural fold formation(GO:0001842) |
23.3 | 93.0 | GO:0003096 | renal sodium ion transport(GO:0003096) |
23.2 | 69.7 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
23.2 | 116.0 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
23.2 | 46.4 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
23.2 | 69.5 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
23.2 | 69.5 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
23.1 | 69.4 | GO:0080009 | mRNA methylation(GO:0080009) |
23.1 | 69.3 | GO:0061623 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
23.1 | 115.4 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
23.0 | 23.0 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
22.9 | 91.5 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
22.9 | 137.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
22.8 | 228.1 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
22.7 | 272.2 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
22.7 | 136.0 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
22.6 | 271.7 | GO:0070828 | heterochromatin organization(GO:0070828) |
22.6 | 90.5 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
22.6 | 203.6 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
22.6 | 22.6 | GO:0071594 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
22.5 | 45.0 | GO:0021924 | cell proliferation in hindbrain(GO:0021534) cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
22.3 | 22.3 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
22.3 | 66.9 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
22.3 | 66.9 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
22.3 | 133.6 | GO:0016266 | O-glycan processing(GO:0016266) |
22.2 | 66.7 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
22.2 | 44.5 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
22.2 | 66.6 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
22.2 | 88.7 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
22.0 | 22.0 | GO:0061184 | positive regulation of dermatome development(GO:0061184) |
22.0 | 43.9 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
21.9 | 65.8 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
21.9 | 263.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
21.9 | 21.9 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
21.9 | 21.9 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
21.9 | 43.8 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
21.9 | 109.3 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
21.8 | 21.8 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
21.8 | 21.8 | GO:1902307 | positive regulation of sodium ion transmembrane transport(GO:1902307) positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
21.8 | 152.3 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
21.7 | 21.7 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
21.7 | 108.7 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
21.7 | 21.7 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
21.7 | 21.7 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
21.6 | 64.9 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
21.6 | 86.4 | GO:0048617 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
21.6 | 64.7 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
21.6 | 237.2 | GO:0007035 | vacuolar acidification(GO:0007035) |
21.5 | 64.6 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
21.4 | 150.1 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
21.4 | 85.6 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
21.4 | 85.5 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
21.3 | 42.6 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
21.3 | 21.3 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
21.2 | 106.2 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
21.2 | 105.8 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
21.1 | 21.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
21.0 | 63.0 | GO:1904747 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
21.0 | 21.0 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
21.0 | 125.8 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
21.0 | 251.4 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
20.9 | 146.5 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
20.9 | 167.5 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
20.9 | 41.9 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
20.9 | 208.9 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
20.9 | 20.9 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
20.8 | 291.6 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
20.8 | 124.7 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
20.8 | 62.3 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
20.7 | 124.3 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
20.7 | 124.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
20.7 | 124.0 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
20.6 | 20.6 | GO:0042117 | monocyte activation(GO:0042117) |
20.5 | 61.5 | GO:0070293 | renal absorption(GO:0070293) |
20.5 | 20.5 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) |
20.4 | 81.7 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
20.4 | 40.9 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
20.4 | 61.3 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
20.4 | 40.8 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
20.4 | 40.8 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
20.4 | 81.5 | GO:0048102 | autophagic cell death(GO:0048102) |
20.4 | 61.1 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
20.3 | 101.7 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
20.3 | 61.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
20.3 | 40.6 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
20.2 | 20.2 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
20.2 | 121.1 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
20.2 | 40.3 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
20.2 | 201.6 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
20.0 | 80.2 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
20.0 | 60.1 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
20.0 | 60.0 | GO:0003032 | detection of oxygen(GO:0003032) |
20.0 | 79.9 | GO:1904752 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
20.0 | 439.2 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
20.0 | 20.0 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
20.0 | 39.9 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
19.9 | 59.8 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
19.9 | 119.1 | GO:0007097 | nuclear migration(GO:0007097) |
19.8 | 19.8 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
19.8 | 39.6 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
19.8 | 19.8 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
19.8 | 59.3 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
19.8 | 39.5 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
19.7 | 39.4 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
19.7 | 39.4 | GO:1900221 | regulation of beta-amyloid clearance(GO:1900221) |
19.6 | 19.6 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
19.6 | 215.7 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
19.6 | 58.7 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
19.5 | 58.6 | GO:0032439 | endosome localization(GO:0032439) |
19.5 | 116.9 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
19.4 | 213.9 | GO:0032801 | receptor catabolic process(GO:0032801) |
19.4 | 19.4 | GO:0006573 | valine metabolic process(GO:0006573) |
19.4 | 155.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
19.4 | 96.9 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
19.3 | 96.7 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
19.3 | 19.3 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
19.3 | 96.4 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
19.3 | 192.5 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
19.1 | 95.5 | GO:0044351 | macropinocytosis(GO:0044351) |
19.1 | 76.4 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
19.1 | 19.1 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
19.1 | 76.3 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
19.1 | 57.2 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
19.0 | 57.1 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
19.0 | 57.1 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
19.0 | 76.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
19.0 | 57.0 | GO:0042938 | dipeptide transport(GO:0042938) |
18.9 | 94.7 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
18.8 | 18.8 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
18.8 | 37.7 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
18.7 | 56.2 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
18.7 | 112.4 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
18.7 | 56.1 | GO:0008228 | opsonization(GO:0008228) |
18.7 | 37.4 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
18.7 | 167.9 | GO:0050872 | white fat cell differentiation(GO:0050872) |
18.6 | 130.5 | GO:0015825 | L-serine transport(GO:0015825) |
18.6 | 74.5 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
18.6 | 409.5 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
18.6 | 55.8 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
18.5 | 18.5 | GO:0003166 | bundle of His development(GO:0003166) |
18.5 | 129.7 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
18.5 | 110.9 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
18.5 | 92.3 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
18.4 | 110.6 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
18.4 | 36.8 | GO:1900238 | cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
18.4 | 18.4 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
18.3 | 18.3 | GO:1903012 | positive regulation of bone development(GO:1903012) |
18.3 | 55.0 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
18.3 | 55.0 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
18.3 | 18.3 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
18.3 | 54.9 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
18.3 | 54.8 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
18.3 | 36.5 | GO:0061010 | gall bladder development(GO:0061010) |
18.2 | 72.7 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
18.2 | 54.5 | GO:1903960 | negative regulation of anion channel activity(GO:0010360) negative regulation of anion transmembrane transport(GO:1903960) |
18.2 | 36.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
18.2 | 54.5 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
18.1 | 18.1 | GO:0031639 | plasminogen activation(GO:0031639) |
18.1 | 72.5 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
18.1 | 72.5 | GO:1902969 | mitotic DNA replication(GO:1902969) |
18.1 | 36.2 | GO:0060023 | soft palate development(GO:0060023) |
18.1 | 126.6 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
18.1 | 54.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
18.1 | 36.2 | GO:1902896 | terminal web assembly(GO:1902896) |
18.1 | 54.2 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
18.0 | 18.0 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
18.0 | 36.0 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
18.0 | 53.9 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
17.9 | 53.8 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
17.9 | 35.9 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
17.9 | 35.9 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
17.9 | 17.9 | GO:0006833 | water transport(GO:0006833) |
17.9 | 71.6 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
17.9 | 53.7 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
17.9 | 143.1 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
17.8 | 124.9 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
17.8 | 53.5 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
17.8 | 89.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
17.8 | 17.8 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
17.7 | 35.5 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
17.7 | 124.0 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
17.7 | 35.4 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
17.6 | 17.6 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
17.6 | 123.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
17.5 | 52.6 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
17.5 | 17.5 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
17.5 | 209.9 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
17.5 | 52.5 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
17.5 | 69.8 | GO:0019081 | viral translation(GO:0019081) IRES-dependent viral translational initiation(GO:0075522) |
17.4 | 34.9 | GO:0018343 | protein farnesylation(GO:0018343) |
17.4 | 34.7 | GO:0009826 | unidimensional cell growth(GO:0009826) |
17.3 | 34.7 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
17.3 | 138.7 | GO:0009437 | carnitine metabolic process(GO:0009437) |
17.3 | 69.3 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
17.3 | 121.2 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
17.3 | 51.9 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
17.2 | 17.2 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
17.2 | 68.7 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
17.2 | 34.3 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
17.2 | 17.2 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
17.1 | 119.8 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
17.0 | 34.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
17.0 | 102.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
17.0 | 51.0 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
17.0 | 33.9 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
16.9 | 50.8 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
16.9 | 33.8 | GO:0006007 | glucose catabolic process(GO:0006007) |
16.9 | 253.7 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
16.9 | 67.6 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
16.9 | 16.9 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
16.8 | 84.2 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
16.8 | 16.8 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
16.8 | 151.3 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
16.8 | 33.6 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
16.8 | 33.6 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
16.8 | 16.8 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
16.8 | 16.8 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
16.8 | 50.3 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
16.7 | 16.7 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
16.7 | 50.1 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
16.7 | 33.4 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
16.7 | 50.1 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
16.7 | 133.5 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
16.7 | 33.3 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
16.6 | 33.2 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
16.6 | 49.8 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
16.5 | 49.4 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
16.4 | 32.9 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
16.4 | 196.6 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
16.4 | 98.2 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
16.3 | 49.0 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
16.3 | 81.6 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
16.3 | 81.5 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
16.3 | 179.2 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
16.3 | 16.3 | GO:0009648 | photoperiodism(GO:0009648) |
16.3 | 65.0 | GO:0060770 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
16.2 | 16.2 | GO:0003383 | apical constriction(GO:0003383) |
16.2 | 16.2 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
16.2 | 32.5 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
16.2 | 97.4 | GO:0043173 | nucleotide salvage(GO:0043173) |
16.2 | 242.9 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
16.2 | 97.0 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
16.1 | 64.5 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
16.1 | 48.2 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
16.0 | 16.0 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
16.0 | 47.9 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
16.0 | 31.9 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
15.9 | 175.2 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
15.9 | 79.5 | GO:1901563 | response to camptothecin(GO:1901563) |
15.8 | 79.2 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
15.8 | 47.5 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
15.8 | 47.5 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
15.8 | 15.8 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
15.8 | 110.6 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
15.8 | 15.8 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
15.8 | 110.3 | GO:0032782 | bile acid secretion(GO:0032782) |
15.7 | 110.2 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
15.7 | 31.4 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
15.7 | 15.7 | GO:0018214 | protein carboxylation(GO:0018214) |
15.6 | 15.6 | GO:0072698 | protein localization to microtubule cytoskeleton(GO:0072698) |
15.6 | 62.5 | GO:0072675 | osteoclast fusion(GO:0072675) |
15.6 | 77.9 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
15.6 | 124.5 | GO:0009299 | mRNA transcription(GO:0009299) |
15.6 | 46.7 | GO:0043149 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
15.5 | 15.5 | GO:0051775 | response to redox state(GO:0051775) |
15.5 | 155.3 | GO:0002115 | store-operated calcium entry(GO:0002115) |
15.5 | 93.2 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
15.5 | 232.9 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
15.5 | 46.5 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
15.5 | 31.0 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
15.5 | 15.5 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
15.4 | 92.6 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
15.4 | 46.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
15.4 | 76.8 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
15.3 | 30.7 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
15.3 | 45.9 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
15.3 | 15.3 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
15.2 | 15.2 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
15.2 | 15.2 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
15.2 | 15.2 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
15.2 | 167.2 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
15.2 | 45.6 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
15.2 | 45.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
15.2 | 15.2 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
15.2 | 90.9 | GO:0045332 | phospholipid translocation(GO:0045332) |
15.1 | 15.1 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
15.1 | 45.4 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
15.1 | 75.7 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
15.1 | 15.1 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
15.1 | 136.1 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
15.1 | 60.4 | GO:0018101 | protein citrullination(GO:0018101) |
15.1 | 60.2 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
15.0 | 45.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
15.0 | 691.4 | GO:0007569 | cell aging(GO:0007569) |
15.0 | 45.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
15.0 | 29.9 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
15.0 | 15.0 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
15.0 | 44.9 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
14.9 | 44.8 | GO:0060487 | lung cell differentiation(GO:0060479) lung epithelial cell differentiation(GO:0060487) |
14.9 | 74.7 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
14.9 | 89.6 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
14.9 | 59.5 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
14.9 | 29.7 | GO:0061084 | negative regulation of protein refolding(GO:0061084) |
14.8 | 29.7 | GO:0043379 | memory T cell differentiation(GO:0043379) |
14.8 | 29.6 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
14.8 | 14.8 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
14.8 | 132.8 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
14.7 | 117.7 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
14.7 | 14.7 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
14.7 | 14.7 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
14.7 | 44.0 | GO:0006449 | regulation of translational termination(GO:0006449) |
14.7 | 146.6 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
14.6 | 43.9 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
14.6 | 73.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
14.6 | 58.3 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
14.6 | 43.7 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
14.6 | 72.9 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
14.6 | 14.6 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
14.6 | 363.9 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
14.6 | 189.2 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
14.5 | 58.2 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
14.5 | 145.4 | GO:0032060 | bleb assembly(GO:0032060) |
14.5 | 57.9 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
14.5 | 115.8 | GO:0071361 | cellular response to ethanol(GO:0071361) |
14.5 | 72.4 | GO:1903671 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) negative regulation of sprouting angiogenesis(GO:1903671) |
14.5 | 43.4 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
14.5 | 72.3 | GO:0072537 | fibroblast activation(GO:0072537) |
14.4 | 14.4 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
14.4 | 43.3 | GO:0015705 | iodide transport(GO:0015705) |
14.4 | 43.3 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
14.4 | 14.4 | GO:0034204 | lipid translocation(GO:0034204) |
14.4 | 28.9 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
14.4 | 14.4 | GO:0006901 | vesicle coating(GO:0006901) |
14.4 | 14.4 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
14.4 | 28.7 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
14.3 | 28.7 | GO:1903416 | response to glycoside(GO:1903416) |
14.3 | 42.9 | GO:0015819 | lysine transport(GO:0015819) |
14.3 | 14.3 | GO:0061511 | centriole elongation(GO:0061511) |
14.3 | 42.8 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
14.3 | 57.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
14.3 | 28.5 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
14.3 | 114.1 | GO:0021670 | lateral ventricle development(GO:0021670) |
14.3 | 85.6 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
14.3 | 85.6 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
14.2 | 71.1 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
14.2 | 56.8 | GO:0006083 | acetate metabolic process(GO:0006083) |
14.2 | 113.7 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
14.2 | 142.0 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
14.2 | 42.5 | GO:0000305 | response to oxygen radical(GO:0000305) |
14.2 | 56.7 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
14.2 | 85.0 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
14.1 | 42.4 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
14.1 | 183.8 | GO:0045116 | protein neddylation(GO:0045116) |
14.1 | 70.6 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
14.1 | 112.9 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
14.1 | 14.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
14.1 | 28.2 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
14.1 | 42.2 | GO:0034214 | protein hexamerization(GO:0034214) |
14.1 | 28.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
14.0 | 28.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
14.0 | 84.2 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
14.0 | 70.1 | GO:0097421 | liver regeneration(GO:0097421) |
14.0 | 42.0 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
14.0 | 70.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
14.0 | 70.0 | GO:0050779 | RNA destabilization(GO:0050779) |
14.0 | 42.0 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
14.0 | 14.0 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
14.0 | 14.0 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
13.9 | 55.7 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
13.9 | 83.3 | GO:0036010 | protein localization to endosome(GO:0036010) |
13.9 | 41.6 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
13.9 | 97.0 | GO:0051014 | actin filament severing(GO:0051014) |
13.9 | 41.6 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
13.8 | 110.6 | GO:0008343 | adult feeding behavior(GO:0008343) |
13.8 | 69.0 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
13.8 | 41.4 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
13.8 | 41.4 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
13.8 | 275.3 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
13.8 | 55.1 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
13.8 | 302.6 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
13.7 | 13.7 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
13.7 | 178.6 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
13.7 | 109.5 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
13.7 | 109.5 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
13.7 | 355.3 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
13.7 | 273.3 | GO:0014823 | response to activity(GO:0014823) |
13.7 | 41.0 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
13.6 | 81.7 | GO:0019985 | translesion synthesis(GO:0019985) |
13.6 | 13.6 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
13.6 | 122.2 | GO:0001893 | maternal placenta development(GO:0001893) |
13.6 | 40.7 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
13.6 | 54.3 | GO:0070459 | prolactin secretion(GO:0070459) |
13.6 | 285.0 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
13.6 | 162.8 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
13.5 | 40.5 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
13.5 | 54.0 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
13.5 | 13.5 | GO:0042921 | corticosteroid receptor signaling pathway(GO:0031958) glucocorticoid receptor signaling pathway(GO:0042921) |
13.5 | 67.4 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
13.5 | 53.9 | GO:0006004 | fucose metabolic process(GO:0006004) |
13.5 | 13.5 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
13.5 | 13.5 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
13.5 | 13.5 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
13.5 | 53.8 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
13.4 | 80.6 | GO:0070254 | mucus secretion(GO:0070254) |
13.4 | 134.2 | GO:0018904 | ether metabolic process(GO:0018904) |
13.4 | 40.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
13.4 | 26.8 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
13.4 | 40.1 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
13.4 | 40.1 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
13.3 | 13.3 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
13.3 | 240.0 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
13.3 | 53.2 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
13.3 | 53.1 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
13.3 | 26.5 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
13.3 | 26.5 | GO:0072718 | response to cisplatin(GO:0072718) |
13.3 | 13.3 | GO:0060068 | vagina development(GO:0060068) |
13.3 | 39.8 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
13.2 | 237.7 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
13.2 | 92.4 | GO:0046040 | IMP metabolic process(GO:0046040) |
13.2 | 92.4 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
13.2 | 39.6 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
13.2 | 13.2 | GO:0045914 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
13.2 | 65.9 | GO:0030033 | microvillus assembly(GO:0030033) |
13.2 | 26.3 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
13.2 | 52.7 | GO:0021590 | cerebellum maturation(GO:0021590) |
13.2 | 52.6 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
13.1 | 302.3 | GO:0043297 | apical junction assembly(GO:0043297) |
13.1 | 26.3 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
13.1 | 39.4 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
13.1 | 236.4 | GO:0016578 | histone deubiquitination(GO:0016578) |
13.1 | 52.5 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
13.1 | 26.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
13.1 | 91.5 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
13.1 | 52.3 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
13.1 | 195.8 | GO:0031648 | protein destabilization(GO:0031648) |
13.0 | 143.1 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
13.0 | 26.0 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
13.0 | 51.8 | GO:0033623 | regulation of integrin activation(GO:0033623) |
12.9 | 77.7 | GO:0002488 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
12.9 | 103.4 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
12.9 | 25.8 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
12.9 | 38.6 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
12.8 | 12.8 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
12.8 | 51.3 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
12.8 | 25.6 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
12.8 | 25.6 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
12.8 | 102.4 | GO:0051383 | kinetochore organization(GO:0051383) |
12.8 | 12.8 | GO:0098792 | xenophagy(GO:0098792) |
12.8 | 12.8 | GO:0048539 | bone marrow development(GO:0048539) |
12.8 | 25.5 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
12.8 | 76.6 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
12.8 | 25.5 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
12.7 | 63.7 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
12.7 | 101.9 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
12.7 | 165.3 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
12.7 | 38.1 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
12.7 | 76.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
12.6 | 25.1 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
12.6 | 37.7 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
12.5 | 37.6 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
12.5 | 62.4 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
12.5 | 49.9 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
12.5 | 24.9 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
12.4 | 124.4 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
12.4 | 24.8 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
12.4 | 49.6 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
12.4 | 37.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
12.4 | 74.1 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
12.4 | 98.8 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
12.3 | 12.3 | GO:0016584 | nucleosome positioning(GO:0016584) |
12.3 | 12.3 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
12.3 | 61.6 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
12.3 | 12.3 | GO:0007143 | female meiotic division(GO:0007143) |
12.3 | 12.3 | GO:0001803 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
12.3 | 24.6 | GO:0010040 | response to iron(II) ion(GO:0010040) |
12.3 | 85.9 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
12.3 | 85.9 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
12.3 | 196.2 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
12.2 | 97.9 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
12.2 | 12.2 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
12.2 | 97.6 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
12.2 | 12.2 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
12.2 | 12.2 | GO:0042559 | tetrahydrobiopterin biosynthetic process(GO:0006729) pteridine-containing compound biosynthetic process(GO:0042559) tetrahydrobiopterin metabolic process(GO:0046146) |
12.2 | 12.2 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
12.1 | 12.1 | GO:0052203 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
12.1 | 24.3 | GO:1903052 | positive regulation of proteolysis involved in cellular protein catabolic process(GO:1903052) |
12.1 | 36.3 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
12.1 | 24.2 | GO:0018158 | protein oxidation(GO:0018158) |
12.1 | 84.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
12.1 | 24.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
12.1 | 36.2 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
12.1 | 24.2 | GO:0060263 | regulation of respiratory burst(GO:0060263) positive regulation of respiratory burst(GO:0060267) |
12.1 | 60.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
12.1 | 229.0 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
12.0 | 36.1 | GO:0015886 | heme transport(GO:0015886) |
12.0 | 48.2 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
12.0 | 240.7 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
12.0 | 24.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
12.0 | 60.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
12.0 | 12.0 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
12.0 | 24.0 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
12.0 | 36.0 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
12.0 | 23.9 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
11.9 | 71.7 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
11.9 | 143.2 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
11.9 | 95.4 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
11.9 | 47.5 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
11.9 | 23.7 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
11.8 | 130.2 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
11.8 | 177.2 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
11.8 | 35.3 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
11.8 | 82.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
11.8 | 58.8 | GO:0045793 | positive regulation of cell size(GO:0045793) |
11.8 | 23.5 | GO:0006907 | pinocytosis(GO:0006907) |
11.8 | 47.0 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
11.7 | 11.7 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
11.7 | 11.7 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
11.7 | 58.6 | GO:0030953 | astral microtubule organization(GO:0030953) |
11.7 | 23.4 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
11.7 | 140.2 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
11.7 | 256.8 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
11.7 | 11.7 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
11.7 | 46.7 | GO:0031929 | TOR signaling(GO:0031929) |
11.6 | 23.3 | GO:0003281 | ventricular septum development(GO:0003281) |
11.6 | 162.8 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
11.6 | 151.2 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
11.6 | 34.9 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
11.6 | 23.2 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
11.6 | 23.2 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
11.6 | 11.6 | GO:0003162 | atrioventricular node development(GO:0003162) |
11.6 | 34.8 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
11.5 | 11.5 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
11.5 | 23.1 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
11.5 | 34.6 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
11.5 | 23.0 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
11.5 | 11.5 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
11.5 | 103.4 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
11.5 | 11.5 | GO:0060631 | regulation of meiosis I(GO:0060631) positive regulation of meiosis I(GO:0060903) |
11.5 | 57.4 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
11.5 | 34.4 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
11.5 | 91.7 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
11.4 | 22.9 | GO:0015755 | fructose transport(GO:0015755) |
11.4 | 45.6 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
11.4 | 22.8 | GO:0030223 | neutrophil differentiation(GO:0030223) |
11.4 | 34.1 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
11.4 | 34.1 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
11.4 | 22.7 | GO:1904705 | regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
11.4 | 22.7 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
11.4 | 56.8 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
11.3 | 22.7 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
11.3 | 11.3 | GO:0030574 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
11.3 | 33.9 | GO:0043921 | modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
11.3 | 11.3 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
11.3 | 11.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
11.3 | 11.3 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
11.3 | 101.5 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
11.2 | 56.2 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
11.2 | 22.4 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
11.2 | 33.6 | GO:0000052 | citrulline metabolic process(GO:0000052) |
11.2 | 11.2 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
11.2 | 201.2 | GO:0006308 | DNA catabolic process(GO:0006308) |
11.2 | 11.2 | GO:0006551 | leucine metabolic process(GO:0006551) |
11.2 | 55.8 | GO:0031053 | primary miRNA processing(GO:0031053) |
11.1 | 66.9 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
11.1 | 11.1 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
11.1 | 11.1 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
11.1 | 22.3 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
11.1 | 33.4 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
11.1 | 55.6 | GO:0006561 | proline biosynthetic process(GO:0006561) |
11.1 | 22.1 | GO:0045923 | positive regulation of fatty acid metabolic process(GO:0045923) |
11.1 | 22.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
11.0 | 44.0 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
11.0 | 44.0 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
11.0 | 11.0 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
11.0 | 21.9 | GO:0006600 | creatine metabolic process(GO:0006600) |
11.0 | 32.9 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
10.9 | 43.8 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
10.9 | 360.4 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
10.9 | 43.7 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
10.9 | 10.9 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
10.9 | 32.7 | GO:0001555 | oocyte growth(GO:0001555) |
10.9 | 239.7 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
10.9 | 21.8 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
10.9 | 10.9 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
10.8 | 21.7 | GO:0019042 | viral latency(GO:0019042) |
10.8 | 10.8 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
10.8 | 21.7 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
10.8 | 10.8 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
10.8 | 21.6 | GO:0060056 | mammary gland involution(GO:0060056) |
10.8 | 64.7 | GO:0007379 | segment specification(GO:0007379) |
10.8 | 32.3 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
10.8 | 43.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
10.8 | 86.1 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
10.8 | 32.3 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
10.7 | 42.9 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
10.7 | 53.6 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
10.7 | 96.3 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
10.7 | 42.7 | GO:0036233 | glycine import(GO:0036233) |
10.7 | 53.3 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
10.6 | 63.9 | GO:0002327 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
10.6 | 10.6 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
10.6 | 31.8 | GO:0009838 | abscission(GO:0009838) |
10.6 | 21.2 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
10.6 | 63.5 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
10.6 | 42.3 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
10.6 | 10.6 | GO:0043129 | surfactant homeostasis(GO:0043129) |
10.5 | 21.1 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
10.5 | 221.3 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
10.5 | 21.1 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
10.5 | 105.1 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
10.5 | 21.0 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
10.5 | 52.5 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
10.5 | 21.0 | GO:0071548 | response to dexamethasone(GO:0071548) |
10.5 | 20.9 | GO:0055088 | lipid homeostasis(GO:0055088) |
10.5 | 31.4 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
10.4 | 62.5 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
10.4 | 10.4 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) |
10.4 | 83.1 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
10.4 | 62.2 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
10.4 | 62.2 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
10.4 | 20.7 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
10.3 | 20.7 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
10.3 | 51.7 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
10.3 | 72.4 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
10.3 | 41.3 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
10.3 | 41.3 | GO:0006824 | cobalt ion transport(GO:0006824) |
10.3 | 30.9 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
10.3 | 10.3 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
10.3 | 10.3 | GO:0060155 | platelet dense granule organization(GO:0060155) |
10.3 | 10.3 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
10.2 | 133.2 | GO:0048821 | erythrocyte development(GO:0048821) |
10.2 | 30.7 | GO:0061042 | vascular wound healing(GO:0061042) |
10.2 | 317.3 | GO:0006611 | protein export from nucleus(GO:0006611) |
10.2 | 40.9 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
10.2 | 10.2 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
10.2 | 30.6 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
10.2 | 10.2 | GO:1901859 | regulation of mitochondrial DNA replication(GO:0090296) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
10.2 | 51.0 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
10.2 | 71.3 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
10.2 | 101.9 | GO:0016574 | histone ubiquitination(GO:0016574) |
10.2 | 20.4 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
10.2 | 81.4 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
10.2 | 10.2 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
10.2 | 50.9 | GO:0070475 | rRNA base methylation(GO:0070475) |
10.2 | 30.5 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
10.2 | 30.5 | GO:0033572 | transferrin transport(GO:0033572) |
10.1 | 50.7 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
10.1 | 30.4 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
10.1 | 50.5 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
10.1 | 50.3 | GO:0042168 | heme metabolic process(GO:0042168) |
10.1 | 20.1 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
10.0 | 20.0 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
10.0 | 10.0 | GO:0042891 | antibiotic transport(GO:0042891) |
10.0 | 70.1 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
10.0 | 10.0 | GO:0036089 | cleavage furrow formation(GO:0036089) |
10.0 | 19.9 | GO:0035973 | aggrephagy(GO:0035973) |
10.0 | 10.0 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
9.9 | 29.8 | GO:0034508 | centromere complex assembly(GO:0034508) |
9.9 | 248.4 | GO:0043966 | histone H3 acetylation(GO:0043966) |
9.9 | 49.7 | GO:0051026 | chiasma assembly(GO:0051026) |
9.9 | 9.9 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
9.9 | 49.6 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
9.9 | 29.7 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
9.9 | 39.5 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
9.9 | 39.5 | GO:0009992 | cellular water homeostasis(GO:0009992) |
9.9 | 147.8 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
9.8 | 9.8 | GO:0051182 | coenzyme transport(GO:0051182) |
9.8 | 19.7 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
9.8 | 58.9 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
9.8 | 19.6 | GO:0048069 | eye pigmentation(GO:0048069) |
9.8 | 19.6 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
9.8 | 9.8 | GO:0043084 | penile erection(GO:0043084) |
9.8 | 48.8 | GO:0006569 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
9.7 | 9.7 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
9.7 | 19.4 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
9.7 | 155.5 | GO:0034340 | response to type I interferon(GO:0034340) |
9.7 | 19.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
9.7 | 9.7 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
9.6 | 125.4 | GO:0016925 | protein sumoylation(GO:0016925) |
9.6 | 19.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
9.6 | 28.8 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
9.6 | 67.1 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
9.6 | 57.5 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
9.6 | 9.6 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
9.6 | 19.1 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
9.6 | 19.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
9.6 | 76.5 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
9.5 | 47.6 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
9.5 | 342.5 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
9.5 | 19.0 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
9.5 | 28.4 | GO:0000032 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
9.4 | 9.4 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
9.4 | 18.8 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
9.4 | 37.6 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
9.4 | 37.6 | GO:0032570 | response to progesterone(GO:0032570) |
9.4 | 18.8 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
9.4 | 18.8 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
9.4 | 28.1 | GO:0015871 | choline transport(GO:0015871) |
9.3 | 37.4 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
9.3 | 46.7 | GO:0046037 | GMP metabolic process(GO:0046037) |
9.3 | 46.7 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
9.3 | 37.3 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
9.3 | 27.9 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
9.3 | 111.8 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
9.3 | 37.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
9.3 | 9.3 | GO:0035384 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
9.3 | 83.6 | GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032434) |
9.3 | 27.8 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
9.3 | 18.5 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
9.3 | 148.2 | GO:0051865 | protein autoubiquitination(GO:0051865) |
9.3 | 27.8 | GO:0032474 | otolith morphogenesis(GO:0032474) |
9.2 | 9.2 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
9.2 | 9.2 | GO:0030421 | defecation(GO:0030421) |
9.2 | 9.2 | GO:0015670 | carbon dioxide transport(GO:0015670) |
9.2 | 137.9 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
9.2 | 146.9 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
9.2 | 36.7 | GO:1904970 | brush border assembly(GO:1904970) |
9.2 | 18.3 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
9.2 | 36.6 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
9.2 | 27.5 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
9.1 | 18.3 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
9.1 | 27.4 | GO:0006116 | NADH oxidation(GO:0006116) |
9.1 | 54.8 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
9.1 | 73.0 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
9.1 | 36.5 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
9.1 | 9.1 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
9.1 | 45.3 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
9.0 | 27.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
9.0 | 90.3 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
9.0 | 45.2 | GO:0032675 | regulation of interleukin-6 production(GO:0032675) |
9.0 | 18.0 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
8.9 | 17.9 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
8.9 | 17.9 | GO:0061450 | trophoblast cell migration(GO:0061450) regulation of trophoblast cell migration(GO:1901163) |
8.9 | 8.9 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
8.9 | 17.8 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
8.9 | 160.0 | GO:0016180 | snRNA processing(GO:0016180) |
8.9 | 88.9 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
8.9 | 35.5 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
8.9 | 17.7 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
8.8 | 26.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
8.8 | 17.7 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
8.8 | 8.8 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
8.8 | 44.2 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
8.8 | 52.8 | GO:0006013 | mannose metabolic process(GO:0006013) |
8.8 | 96.7 | GO:2000378 | negative regulation of reactive oxygen species metabolic process(GO:2000378) |
8.8 | 26.3 | GO:0019086 | late viral transcription(GO:0019086) |
8.8 | 17.6 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
8.8 | 26.3 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
8.8 | 52.6 | GO:0031167 | rRNA methylation(GO:0031167) |
8.8 | 26.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
8.8 | 52.6 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
8.8 | 17.5 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
8.7 | 8.7 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
8.7 | 17.5 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
8.7 | 17.4 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
8.7 | 43.5 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
8.7 | 34.7 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
8.7 | 60.8 | GO:0043954 | cellular component maintenance(GO:0043954) |
8.7 | 8.7 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
8.7 | 17.3 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
8.7 | 34.6 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
8.6 | 25.9 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
8.6 | 17.2 | GO:0051782 | negative regulation of cell division(GO:0051782) |
8.6 | 68.7 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
8.6 | 34.3 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
8.6 | 17.2 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
8.6 | 8.6 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
8.6 | 25.7 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
8.5 | 8.5 | GO:0010874 | regulation of cholesterol efflux(GO:0010874) |
8.5 | 17.0 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
8.5 | 8.5 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
8.5 | 8.5 | GO:0044252 | negative regulation of multicellular organismal metabolic process(GO:0044252) |
8.5 | 76.2 | GO:0015732 | prostaglandin transport(GO:0015732) |
8.5 | 42.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
8.5 | 236.8 | GO:0006749 | glutathione metabolic process(GO:0006749) |
8.5 | 33.8 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
8.5 | 8.5 | GO:0060157 | urinary bladder development(GO:0060157) |
8.4 | 565.1 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
8.4 | 33.7 | GO:0070670 | response to interleukin-4(GO:0070670) |
8.4 | 185.2 | GO:0034728 | nucleosome organization(GO:0034728) |
8.4 | 50.4 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
8.4 | 25.2 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
8.4 | 25.2 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
8.4 | 58.8 | GO:0035493 | SNARE complex assembly(GO:0035493) |
8.4 | 25.2 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
8.4 | 25.1 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
8.4 | 8.4 | GO:2000738 | positive regulation of stem cell differentiation(GO:2000738) |
8.4 | 175.8 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) |
8.4 | 8.4 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
8.4 | 8.4 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
8.4 | 58.5 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
8.4 | 8.4 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
8.3 | 8.3 | GO:0045176 | apical protein localization(GO:0045176) |
8.3 | 8.3 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
8.3 | 16.6 | GO:0046112 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) nucleobase biosynthetic process(GO:0046112) |
8.3 | 16.6 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
8.3 | 16.6 | GO:0070268 | cornification(GO:0070268) |
8.3 | 16.6 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
8.3 | 58.0 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
8.3 | 16.5 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
8.3 | 8.3 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
8.2 | 24.7 | GO:0010039 | response to iron ion(GO:0010039) |
8.2 | 8.2 | GO:2000667 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) positive regulation of interleukin-5 secretion(GO:2000664) regulation of interleukin-13 secretion(GO:2000665) positive regulation of interleukin-13 secretion(GO:2000667) |
8.2 | 33.0 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
8.2 | 8.2 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
8.2 | 49.2 | GO:0070986 | left/right axis specification(GO:0070986) |
8.2 | 8.2 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
8.2 | 89.8 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
8.2 | 8.2 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
8.1 | 24.4 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
8.1 | 40.7 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
8.1 | 16.3 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
8.1 | 65.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
8.1 | 24.4 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
8.1 | 24.4 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
8.1 | 8.1 | GO:1904181 | positive regulation of membrane depolarization(GO:1904181) |
8.1 | 24.3 | GO:0032642 | regulation of chemokine production(GO:0032642) |
8.1 | 16.2 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
8.1 | 16.1 | GO:1904424 | regulation of GTP binding(GO:1904424) |
8.1 | 16.1 | GO:1903998 | regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) |
8.1 | 8.1 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
8.0 | 24.1 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
8.0 | 40.2 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
8.0 | 32.1 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
8.0 | 16.0 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
8.0 | 8.0 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
8.0 | 32.0 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
8.0 | 24.0 | GO:0032099 | negative regulation of appetite(GO:0032099) |
8.0 | 120.0 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
8.0 | 8.0 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
8.0 | 16.0 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
8.0 | 32.0 | GO:0071800 | podosome assembly(GO:0071800) |
8.0 | 71.8 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
8.0 | 31.9 | GO:0043312 | neutrophil degranulation(GO:0043312) |
8.0 | 63.7 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
8.0 | 23.9 | GO:0016572 | histone phosphorylation(GO:0016572) |
8.0 | 8.0 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) regulation of hemoglobin biosynthetic process(GO:0046984) |
7.9 | 55.6 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
7.9 | 23.8 | GO:0006301 | postreplication repair(GO:0006301) |
7.9 | 23.8 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
7.9 | 23.8 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
7.9 | 23.7 | GO:0001556 | oocyte maturation(GO:0001556) |
7.9 | 31.6 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
7.9 | 15.8 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
7.9 | 15.8 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
7.9 | 86.9 | GO:0051601 | exocyst localization(GO:0051601) |
7.9 | 23.6 | GO:0045740 | positive regulation of DNA replication(GO:0045740) |
7.9 | 63.0 | GO:0048535 | lymph node development(GO:0048535) |
7.9 | 94.5 | GO:0021591 | ventricular system development(GO:0021591) |
7.9 | 189.0 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
7.9 | 31.4 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
7.8 | 15.6 | GO:0010212 | response to ionizing radiation(GO:0010212) |
7.8 | 7.8 | GO:0032108 | negative regulation of response to extracellular stimulus(GO:0032105) negative regulation of response to nutrient levels(GO:0032108) |
7.8 | 23.4 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
7.8 | 23.3 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
7.8 | 15.6 | GO:0042506 | tyrosine phosphorylation of Stat5 protein(GO:0042506) |
7.8 | 7.8 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
7.8 | 31.1 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
7.8 | 38.8 | GO:1901070 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) guanosine-containing compound biosynthetic process(GO:1901070) |
7.8 | 31.1 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
7.8 | 31.0 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
7.8 | 69.8 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
7.7 | 46.5 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
7.7 | 7.7 | GO:0043620 | regulation of DNA-templated transcription in response to stress(GO:0043620) |
7.7 | 30.9 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
7.7 | 7.7 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
7.7 | 69.3 | GO:0051492 | regulation of stress fiber assembly(GO:0051492) |
7.7 | 15.4 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
7.7 | 53.8 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
7.7 | 7.7 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
7.7 | 7.7 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
7.6 | 22.9 | GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) |
7.6 | 15.3 | GO:1904938 | dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
7.6 | 152.3 | GO:0006338 | chromatin remodeling(GO:0006338) |
7.6 | 7.6 | GO:0046036 | CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) |
7.6 | 7.6 | GO:0071321 | cellular response to cGMP(GO:0071321) |
7.6 | 15.2 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
7.6 | 53.2 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
7.6 | 15.2 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
7.6 | 15.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
7.6 | 121.2 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
7.6 | 15.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
7.6 | 7.6 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
7.5 | 37.7 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
7.5 | 15.1 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
7.5 | 203.6 | GO:0065002 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
7.5 | 22.6 | GO:0006742 | NADP catabolic process(GO:0006742) |
7.5 | 7.5 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
7.5 | 37.6 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
7.5 | 15.0 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
7.5 | 171.9 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
7.5 | 14.9 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
7.5 | 238.6 | GO:0090630 | activation of GTPase activity(GO:0090630) |
7.4 | 44.7 | GO:0060009 | Sertoli cell development(GO:0060009) |
7.4 | 22.3 | GO:0032965 | regulation of collagen biosynthetic process(GO:0032965) |
7.4 | 22.3 | GO:0090527 | actin filament reorganization(GO:0090527) |
7.4 | 14.9 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
7.4 | 66.8 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
7.4 | 14.8 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
7.4 | 7.4 | GO:0008053 | mitochondrial fusion(GO:0008053) |
7.4 | 51.8 | GO:0015858 | nucleoside transport(GO:0015858) |
7.4 | 7.4 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
7.4 | 177.4 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
7.4 | 7.4 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
7.4 | 29.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
7.4 | 22.1 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
7.4 | 7.4 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
7.4 | 14.7 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
7.4 | 36.8 | GO:0046599 | regulation of centriole replication(GO:0046599) |
7.4 | 14.7 | GO:0015889 | cobalamin transport(GO:0015889) |
7.3 | 73.4 | GO:0070208 | protein heterotrimerization(GO:0070208) |
7.3 | 14.6 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
7.3 | 43.9 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
7.3 | 7.3 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
7.3 | 72.9 | GO:0043968 | histone H2A acetylation(GO:0043968) |
7.3 | 43.7 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
7.3 | 21.8 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
7.2 | 29.0 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
7.2 | 224.3 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
7.2 | 65.1 | GO:0060674 | placenta blood vessel development(GO:0060674) |
7.2 | 21.7 | GO:0051785 | positive regulation of nuclear division(GO:0051785) |
7.2 | 36.1 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
7.2 | 57.6 | GO:0016926 | protein desumoylation(GO:0016926) |
7.2 | 14.4 | GO:0006068 | ethanol catabolic process(GO:0006068) |
7.2 | 28.6 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
7.2 | 28.6 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
7.2 | 14.3 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
7.1 | 14.3 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
7.1 | 28.6 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
7.1 | 14.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
7.1 | 14.3 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
7.1 | 21.4 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
7.1 | 78.4 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
7.1 | 71.2 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
7.1 | 35.5 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
7.1 | 28.4 | GO:0009404 | toxin metabolic process(GO:0009404) |
7.1 | 21.2 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
7.1 | 42.4 | GO:0050931 | pigment cell differentiation(GO:0050931) |
7.1 | 84.7 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
7.1 | 14.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
7.0 | 70.4 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
7.0 | 21.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
7.0 | 28.1 | GO:0046686 | response to cadmium ion(GO:0046686) |
7.0 | 63.3 | GO:0030049 | muscle filament sliding(GO:0030049) |
7.0 | 175.6 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
7.0 | 28.1 | GO:0042737 | drug catabolic process(GO:0042737) |
7.0 | 7.0 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
7.0 | 63.0 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
7.0 | 41.9 | GO:0051084 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
7.0 | 188.2 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
7.0 | 7.0 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
7.0 | 62.6 | GO:0043206 | extracellular fibril organization(GO:0043206) |
7.0 | 69.5 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
6.9 | 13.9 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
6.9 | 41.7 | GO:0030449 | regulation of complement activation(GO:0030449) |
6.9 | 27.7 | GO:0033227 | dsRNA transport(GO:0033227) |
6.9 | 34.6 | GO:0006903 | vesicle targeting(GO:0006903) |
6.9 | 41.5 | GO:0046039 | GTP metabolic process(GO:0046039) |
6.9 | 20.7 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
6.9 | 55.1 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
6.9 | 110.2 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
6.9 | 6.9 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
6.9 | 27.5 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
6.9 | 13.7 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
6.9 | 102.9 | GO:0000266 | mitochondrial fission(GO:0000266) |
6.9 | 6.9 | GO:0072663 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
6.8 | 20.5 | GO:0009629 | response to gravity(GO:0009629) |
6.8 | 34.1 | GO:0042448 | progesterone metabolic process(GO:0042448) |
6.8 | 34.1 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
6.8 | 13.6 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
6.8 | 13.6 | GO:0006298 | mismatch repair(GO:0006298) |
6.8 | 13.6 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
6.8 | 20.3 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
6.8 | 20.3 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
6.8 | 6.8 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
6.8 | 6.8 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
6.7 | 27.0 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
6.7 | 6.7 | GO:0034032 | nucleoside bisphosphate metabolic process(GO:0033865) ribonucleoside bisphosphate metabolic process(GO:0033875) purine nucleoside bisphosphate metabolic process(GO:0034032) |
6.7 | 6.7 | GO:0060539 | diaphragm development(GO:0060539) |
6.7 | 87.5 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
6.7 | 13.4 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
6.7 | 53.6 | GO:1903146 | regulation of mitophagy(GO:1903146) |
6.7 | 6.7 | GO:0050892 | intestinal absorption(GO:0050892) |
6.7 | 33.4 | GO:0034629 | cellular protein complex localization(GO:0034629) |
6.7 | 13.4 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
6.7 | 46.7 | GO:0072678 | T cell migration(GO:0072678) |
6.7 | 46.6 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
6.6 | 6.6 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
6.6 | 19.9 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
6.6 | 26.5 | GO:0006855 | drug transmembrane transport(GO:0006855) |
6.6 | 26.5 | GO:0014888 | striated muscle adaptation(GO:0014888) |
6.6 | 86.1 | GO:0016575 | histone deacetylation(GO:0016575) |
6.6 | 6.6 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
6.6 | 19.8 | GO:0070542 | response to fatty acid(GO:0070542) |
6.6 | 72.5 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
6.6 | 6.6 | GO:2000756 | regulation of peptidyl-lysine acetylation(GO:2000756) |
6.6 | 46.1 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
6.6 | 6.6 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
6.6 | 6.6 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
6.6 | 6.6 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
6.5 | 6.5 | GO:0014841 | skeletal muscle satellite cell proliferation(GO:0014841) |
6.5 | 6.5 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
6.5 | 97.9 | GO:0006801 | superoxide metabolic process(GO:0006801) |
6.5 | 39.1 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
6.5 | 58.6 | GO:0001706 | endoderm formation(GO:0001706) |
6.5 | 65.0 | GO:0001675 | acrosome assembly(GO:0001675) |
6.5 | 13.0 | GO:0060613 | fat pad development(GO:0060613) |
6.5 | 6.5 | GO:0035799 | ureter maturation(GO:0035799) |
6.5 | 13.0 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
6.5 | 32.4 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
6.5 | 6.5 | GO:0016073 | snRNA metabolic process(GO:0016073) |
6.5 | 12.9 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
6.5 | 12.9 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
6.5 | 71.1 | GO:0048753 | pigment granule organization(GO:0048753) |
6.4 | 12.9 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
6.4 | 32.1 | GO:0043405 | regulation of MAP kinase activity(GO:0043405) |
6.4 | 25.6 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
6.4 | 12.8 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
6.4 | 51.1 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
6.4 | 31.9 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
6.4 | 19.1 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
6.3 | 272.2 | GO:0051028 | mRNA transport(GO:0051028) |
6.3 | 6.3 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
6.3 | 18.9 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
6.3 | 6.3 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
6.3 | 6.3 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
6.3 | 44.1 | GO:0006817 | phosphate ion transport(GO:0006817) |
6.3 | 25.2 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
6.3 | 6.3 | GO:0040033 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
6.3 | 25.1 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
6.3 | 6.3 | GO:0021569 | rhombomere 3 development(GO:0021569) |
6.3 | 12.5 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
6.3 | 37.6 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
6.3 | 6.3 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
6.3 | 219.3 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
6.3 | 43.8 | GO:0071824 | protein-DNA complex subunit organization(GO:0071824) |
6.3 | 6.3 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
6.2 | 31.2 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
6.2 | 136.7 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
6.2 | 18.6 | GO:0034101 | erythrocyte homeostasis(GO:0034101) |
6.2 | 6.2 | GO:0071467 | cellular response to pH(GO:0071467) |
6.2 | 24.8 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
6.2 | 18.5 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
6.2 | 86.5 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
6.2 | 104.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
6.2 | 18.5 | GO:0006525 | arginine metabolic process(GO:0006525) |
6.1 | 24.6 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
6.1 | 6.1 | GO:1901631 | positive regulation of presynaptic membrane organization(GO:1901631) |
6.1 | 12.2 | GO:0072224 | metanephric glomerulus development(GO:0072224) |
6.1 | 12.2 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
6.1 | 12.2 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
6.1 | 61.0 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
6.1 | 18.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
6.1 | 12.2 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
6.1 | 12.2 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
6.1 | 103.3 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
6.1 | 12.1 | GO:0006868 | glutamine transport(GO:0006868) |
6.1 | 36.3 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
6.0 | 78.5 | GO:0051168 | nuclear export(GO:0051168) |
6.0 | 30.2 | GO:0006528 | asparagine metabolic process(GO:0006528) |
6.0 | 42.1 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
6.0 | 12.0 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
6.0 | 12.0 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
6.0 | 54.0 | GO:0008340 | determination of adult lifespan(GO:0008340) |
6.0 | 12.0 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
6.0 | 30.0 | GO:0071711 | basement membrane organization(GO:0071711) |
5.9 | 17.8 | GO:0036035 | osteoclast development(GO:0036035) |
5.9 | 5.9 | GO:0048865 | stem cell fate commitment(GO:0048865) |
5.9 | 11.8 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
5.9 | 11.8 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
5.9 | 23.6 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
5.9 | 47.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
5.9 | 29.5 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
5.9 | 11.8 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
5.9 | 135.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
5.9 | 11.8 | GO:0031268 | pseudopodium organization(GO:0031268) |
5.9 | 5.9 | GO:0006415 | translational termination(GO:0006415) |
5.9 | 410.9 | GO:0016568 | chromatin modification(GO:0016568) |
5.9 | 23.5 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
5.9 | 445.9 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
5.9 | 17.6 | GO:0015671 | oxygen transport(GO:0015671) |
5.9 | 5.9 | GO:0051057 | positive regulation of small GTPase mediated signal transduction(GO:0051057) |
5.9 | 17.6 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
5.8 | 5.8 | GO:0022011 | Schwann cell development(GO:0014044) myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
5.8 | 5.8 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
5.8 | 5.8 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
5.8 | 17.5 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
5.8 | 17.4 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
5.8 | 86.9 | GO:0000045 | autophagosome assembly(GO:0000045) |
5.8 | 63.5 | GO:0017144 | drug metabolic process(GO:0017144) |
5.8 | 17.3 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
5.7 | 74.7 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
5.7 | 5.7 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
5.7 | 51.6 | GO:0007099 | centriole replication(GO:0007099) |
5.7 | 5.7 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
5.7 | 17.2 | GO:0044346 | fibroblast apoptotic process(GO:0044346) regulation of fibroblast apoptotic process(GO:2000269) |
5.7 | 5.7 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
5.7 | 28.5 | GO:0071318 | cellular response to ATP(GO:0071318) |
5.7 | 17.1 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
5.7 | 11.4 | GO:0002576 | platelet degranulation(GO:0002576) |
5.7 | 11.4 | GO:0048368 | lateral mesoderm development(GO:0048368) |
5.7 | 5.7 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
5.7 | 17.0 | GO:0010225 | response to UV-C(GO:0010225) |
5.7 | 62.3 | GO:0045682 | regulation of epidermis development(GO:0045682) |
5.7 | 11.3 | GO:1902652 | secondary alcohol metabolic process(GO:1902652) |
5.7 | 17.0 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
5.7 | 56.6 | GO:0042730 | fibrinolysis(GO:0042730) |
5.7 | 17.0 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
5.6 | 16.9 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
5.6 | 28.2 | GO:0046415 | urate metabolic process(GO:0046415) |
5.6 | 22.5 | GO:0016264 | gap junction assembly(GO:0016264) |
5.6 | 95.6 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
5.6 | 5.6 | GO:1902306 | negative regulation of sodium ion transmembrane transport(GO:1902306) |
5.6 | 16.8 | GO:0030202 | heparin metabolic process(GO:0030202) |
5.6 | 72.8 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
5.6 | 28.0 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
5.6 | 295.7 | GO:0007051 | spindle organization(GO:0007051) |
5.6 | 5.6 | GO:0007031 | peroxisome organization(GO:0007031) |
5.6 | 22.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
5.5 | 11.1 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
5.5 | 11.1 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
5.5 | 11.0 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
5.5 | 88.3 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) regulation of cyclin-dependent protein kinase activity(GO:1904029) |
5.5 | 27.6 | GO:0000103 | sulfate assimilation(GO:0000103) |
5.5 | 16.5 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
5.5 | 16.5 | GO:1990776 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
5.5 | 22.0 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
5.5 | 5.5 | GO:0030242 | pexophagy(GO:0030242) |
5.5 | 16.5 | GO:0042026 | protein refolding(GO:0042026) |
5.5 | 27.4 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
5.5 | 5.5 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
5.5 | 16.4 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) |
5.5 | 21.8 | GO:0007000 | nucleolus organization(GO:0007000) |
5.5 | 10.9 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
5.4 | 5.4 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
5.4 | 5.4 | GO:0015817 | histidine transport(GO:0015817) |
5.4 | 16.2 | GO:0031054 | pre-miRNA processing(GO:0031054) |
5.4 | 16.2 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
5.4 | 32.3 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
5.4 | 37.6 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
5.4 | 75.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
5.4 | 5.4 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
5.4 | 21.4 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
5.3 | 21.4 | GO:0034227 | tRNA thio-modification(GO:0034227) |
5.3 | 16.0 | GO:0042420 | dopamine catabolic process(GO:0042420) |
5.3 | 47.9 | GO:0072331 | signal transduction by p53 class mediator(GO:0072331) |
5.3 | 53.1 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
5.3 | 5.3 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
5.3 | 126.9 | GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process(GO:0043161) |
5.3 | 42.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
5.3 | 21.1 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
5.3 | 21.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
5.3 | 10.5 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
5.3 | 21.1 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
5.3 | 10.5 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
5.2 | 47.1 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
5.2 | 5.2 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
5.2 | 5.2 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
5.2 | 203.3 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
5.2 | 15.6 | GO:0006857 | oligopeptide transport(GO:0006857) |
5.2 | 10.4 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
5.2 | 62.2 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
5.2 | 114.1 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
5.2 | 31.1 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
5.2 | 10.4 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
5.2 | 20.7 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
5.2 | 15.5 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
5.2 | 46.4 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
5.2 | 30.9 | GO:0033044 | regulation of chromosome organization(GO:0033044) |
5.2 | 77.3 | GO:0006829 | zinc II ion transport(GO:0006829) |
5.2 | 25.8 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
5.1 | 56.5 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
5.1 | 5.1 | GO:0006476 | protein deacetylation(GO:0006476) |
5.1 | 30.8 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
5.1 | 35.9 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
5.1 | 92.3 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
5.1 | 25.6 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
5.1 | 10.2 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
5.1 | 81.7 | GO:0070527 | platelet aggregation(GO:0070527) |
5.1 | 5.1 | GO:0009650 | UV protection(GO:0009650) |
5.1 | 15.3 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
5.1 | 101.7 | GO:1901998 | toxin transport(GO:1901998) |
5.1 | 71.2 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
5.1 | 5.1 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
5.0 | 25.2 | GO:0000154 | rRNA modification(GO:0000154) |
5.0 | 115.4 | GO:0045454 | cell redox homeostasis(GO:0045454) |
5.0 | 20.0 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
5.0 | 35.0 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
5.0 | 29.9 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
5.0 | 20.0 | GO:0071514 | genetic imprinting(GO:0071514) |
5.0 | 10.0 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
5.0 | 34.9 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
5.0 | 164.2 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
5.0 | 14.9 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
4.9 | 14.8 | GO:0016559 | peroxisome fission(GO:0016559) |
4.9 | 14.8 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
4.9 | 44.3 | GO:0002385 | mucosal immune response(GO:0002385) |
4.9 | 29.4 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
4.9 | 78.2 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
4.9 | 4.9 | GO:0030811 | regulation of nucleotide catabolic process(GO:0030811) |
4.9 | 9.7 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
4.9 | 4.9 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
4.8 | 14.5 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
4.8 | 14.5 | GO:0035510 | DNA dealkylation(GO:0035510) |
4.8 | 19.4 | GO:0001841 | neural tube formation(GO:0001841) |
4.8 | 9.7 | GO:0031018 | endocrine pancreas development(GO:0031018) |
4.8 | 4.8 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
4.8 | 4.8 | GO:0003351 | epithelial cilium movement(GO:0003351) |
4.8 | 24.0 | GO:0000723 | telomere maintenance(GO:0000723) telomere organization(GO:0032200) |
4.8 | 9.6 | GO:0042510 | regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
4.8 | 4.8 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
4.8 | 52.5 | GO:0009267 | cellular response to starvation(GO:0009267) |
4.8 | 4.8 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
4.8 | 9.5 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
4.8 | 4.8 | GO:0048625 | myoblast fate commitment(GO:0048625) |
4.7 | 71.2 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
4.7 | 23.7 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
4.7 | 9.5 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
4.7 | 4.7 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
4.7 | 32.9 | GO:0042574 | retinal metabolic process(GO:0042574) |
4.7 | 9.4 | GO:0071359 | cellular response to dsRNA(GO:0071359) |
4.7 | 51.7 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
4.7 | 4.7 | GO:0045061 | negative thymic T cell selection(GO:0045060) thymic T cell selection(GO:0045061) |
4.7 | 4.7 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
4.7 | 9.4 | GO:0030852 | regulation of granulocyte differentiation(GO:0030852) |
4.7 | 9.3 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
4.7 | 32.7 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
4.7 | 65.3 | GO:0006284 | base-excision repair(GO:0006284) |
4.7 | 9.3 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
4.6 | 83.6 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
4.6 | 27.8 | GO:0061515 | myeloid cell development(GO:0061515) |
4.6 | 18.5 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
4.6 | 41.7 | GO:0061436 | regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
4.6 | 13.9 | GO:0051639 | actin filament network formation(GO:0051639) |
4.6 | 23.0 | GO:0051013 | microtubule severing(GO:0051013) |
4.6 | 4.6 | GO:0019083 | viral transcription(GO:0019083) |
4.6 | 23.0 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
4.6 | 4.6 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
4.6 | 9.2 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
4.6 | 133.0 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
4.6 | 32.0 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
4.6 | 132.5 | GO:0007059 | chromosome segregation(GO:0007059) |
4.6 | 13.7 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
4.5 | 4.5 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
4.5 | 4.5 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
4.5 | 49.7 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
4.5 | 27.1 | GO:0030168 | platelet activation(GO:0030168) |
4.5 | 13.5 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
4.5 | 9.0 | GO:1903543 | regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
4.5 | 4.5 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
4.5 | 13.5 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
4.5 | 17.9 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
4.5 | 9.0 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
4.5 | 4.5 | GO:0051464 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
4.5 | 17.9 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
4.5 | 8.9 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
4.5 | 4.5 | GO:0021570 | rhombomere 4 development(GO:0021570) |
4.4 | 53.3 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
4.4 | 101.9 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
4.4 | 13.3 | GO:0050832 | defense response to fungus(GO:0050832) |
4.4 | 57.6 | GO:0006446 | regulation of translational initiation(GO:0006446) |
4.4 | 35.4 | GO:0010634 | positive regulation of epithelial cell migration(GO:0010634) |
4.4 | 17.7 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
4.4 | 57.2 | GO:0051591 | response to cAMP(GO:0051591) |
4.4 | 26.4 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
4.4 | 4.4 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
4.4 | 8.8 | GO:0015846 | polyamine transport(GO:0015846) |
4.4 | 4.4 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
4.4 | 4.4 | GO:0070266 | necroptotic process(GO:0070266) |
4.3 | 52.2 | GO:0048286 | lung alveolus development(GO:0048286) |
4.3 | 17.2 | GO:0030261 | chromosome condensation(GO:0030261) |
4.3 | 17.2 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
4.3 | 17.2 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
4.3 | 90.1 | GO:0042073 | intraciliary transport(GO:0042073) |
4.3 | 4.3 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) positive regulation of monocyte differentiation(GO:0045657) |
4.3 | 128.6 | GO:0051321 | meiotic cell cycle(GO:0051321) |
4.3 | 4.3 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
4.3 | 4.3 | GO:0032800 | receptor biosynthetic process(GO:0032800) |
4.3 | 8.5 | GO:0006768 | biotin metabolic process(GO:0006768) |
4.2 | 4.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
4.2 | 8.5 | GO:0007088 | regulation of mitotic nuclear division(GO:0007088) |
4.2 | 21.2 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
4.2 | 16.9 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
4.2 | 71.6 | GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity(GO:0043433) |
4.2 | 12.6 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
4.2 | 155.4 | GO:0016071 | mRNA metabolic process(GO:0016071) |
4.2 | 4.2 | GO:0035112 | genitalia morphogenesis(GO:0035112) |
4.2 | 54.5 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
4.2 | 33.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
4.2 | 25.0 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
4.2 | 12.5 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
4.2 | 29.1 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
4.2 | 16.6 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
4.1 | 28.9 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
4.1 | 16.5 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
4.1 | 4.1 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
4.1 | 8.2 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
4.1 | 4.1 | GO:2000779 | regulation of double-strand break repair(GO:2000779) |
4.1 | 8.2 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
4.1 | 12.3 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
4.1 | 8.2 | GO:0002215 | defense response to nematode(GO:0002215) |
4.1 | 114.3 | GO:0006909 | phagocytosis(GO:0006909) |
4.1 | 4.1 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
4.1 | 56.9 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
4.1 | 20.3 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
4.1 | 16.2 | GO:0002825 | regulation of T-helper 1 type immune response(GO:0002825) |
4.1 | 12.2 | GO:0060037 | pharyngeal system development(GO:0060037) |
4.0 | 24.3 | GO:0035608 | protein deglutamylation(GO:0035608) |
4.0 | 64.7 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
4.0 | 8.0 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
4.0 | 12.0 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
4.0 | 8.0 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
4.0 | 16.0 | GO:0042756 | drinking behavior(GO:0042756) |
4.0 | 55.8 | GO:0035904 | aorta development(GO:0035904) |
4.0 | 19.9 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
4.0 | 27.9 | GO:0042832 | defense response to protozoan(GO:0042832) |
3.9 | 15.8 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
3.9 | 31.5 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
3.9 | 3.9 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
3.9 | 3.9 | GO:0051985 | negative regulation of chromosome segregation(GO:0051985) |
3.9 | 11.7 | GO:0006563 | L-serine metabolic process(GO:0006563) L-serine biosynthetic process(GO:0006564) |
3.9 | 27.4 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
3.9 | 11.7 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) |
3.9 | 11.7 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
3.9 | 70.3 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
3.9 | 7.8 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
3.9 | 314.7 | GO:0032259 | methylation(GO:0032259) |
3.9 | 3.9 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
3.9 | 3.9 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
3.9 | 7.8 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
3.9 | 15.5 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
3.9 | 7.7 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
3.9 | 65.5 | GO:0007030 | Golgi organization(GO:0007030) |
3.8 | 7.7 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
3.8 | 3.8 | GO:0046033 | AMP metabolic process(GO:0046033) |
3.8 | 3.8 | GO:0061437 | renal system vasculature development(GO:0061437) kidney vasculature development(GO:0061440) glomerulus vasculature development(GO:0072012) |
3.8 | 19.1 | GO:0007140 | male meiosis(GO:0007140) |
3.8 | 11.4 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
3.8 | 79.9 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
3.8 | 83.7 | GO:0007265 | Ras protein signal transduction(GO:0007265) |
3.8 | 34.0 | GO:0007004 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
3.8 | 3.8 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
3.8 | 7.5 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
3.8 | 519.4 | GO:0016567 | protein ubiquitination(GO:0016567) |
3.8 | 3.8 | GO:0051657 | maintenance of organelle location(GO:0051657) |
3.8 | 94.0 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
3.8 | 18.8 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
3.7 | 22.5 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
3.7 | 7.5 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
3.7 | 3.7 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
3.7 | 123.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
3.7 | 3.7 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
3.7 | 18.6 | GO:0009303 | rRNA transcription(GO:0009303) |
3.7 | 7.4 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
3.7 | 77.6 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
3.7 | 3.7 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
3.7 | 11.1 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
3.7 | 7.4 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
3.7 | 7.4 | GO:0035455 | response to interferon-alpha(GO:0035455) |
3.7 | 7.3 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
3.7 | 7.3 | GO:0061512 | protein localization to cilium(GO:0061512) |
3.7 | 18.3 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
3.7 | 3.7 | GO:0051023 | regulation of immunoglobulin secretion(GO:0051023) |
3.7 | 3.7 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
3.7 | 11.0 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
3.7 | 127.8 | GO:0006457 | protein folding(GO:0006457) |
3.6 | 40.1 | GO:0042246 | tissue regeneration(GO:0042246) |
3.6 | 47.4 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
3.6 | 39.7 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
3.6 | 3.6 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
3.6 | 32.2 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
3.6 | 10.7 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
3.6 | 68.0 | GO:0060324 | face development(GO:0060324) |
3.6 | 14.3 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
3.5 | 113.5 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
3.5 | 7.1 | GO:0097066 | response to thyroid hormone(GO:0097066) |
3.5 | 269.4 | GO:0006869 | lipid transport(GO:0006869) |
3.5 | 7.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
3.5 | 17.7 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
3.5 | 28.3 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
3.5 | 7.1 | GO:0045911 | positive regulation of DNA recombination(GO:0045911) |
3.5 | 3.5 | GO:0040009 | regulation of growth rate(GO:0040009) |
3.5 | 17.6 | GO:0046677 | response to antibiotic(GO:0046677) |
3.5 | 3.5 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
3.5 | 38.3 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
3.5 | 27.8 | GO:0032680 | regulation of tumor necrosis factor production(GO:0032680) |
3.5 | 17.4 | GO:0046085 | adenosine metabolic process(GO:0046085) |
3.5 | 3.5 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
3.5 | 938.5 | GO:0045892 | negative regulation of transcription, DNA-templated(GO:0045892) |
3.5 | 41.5 | GO:0043627 | response to estrogen(GO:0043627) |
3.5 | 17.3 | GO:0042990 | regulation of transcription factor import into nucleus(GO:0042990) |
3.4 | 31.0 | GO:0045047 | protein targeting to ER(GO:0045047) |
3.4 | 10.3 | GO:0019321 | pentose metabolic process(GO:0019321) |
3.4 | 3.4 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
3.4 | 17.0 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
3.4 | 30.5 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
3.4 | 77.9 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
3.4 | 13.5 | GO:0050704 | regulation of interleukin-1 secretion(GO:0050704) |
3.4 | 3.4 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
3.4 | 16.8 | GO:0018200 | protein polyglutamylation(GO:0018095) peptidyl-glutamic acid modification(GO:0018200) |
3.4 | 77.5 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
3.4 | 3.4 | GO:0048340 | paraxial mesoderm morphogenesis(GO:0048340) paraxial mesoderm formation(GO:0048341) |
3.4 | 13.4 | GO:0001771 | immunological synapse formation(GO:0001771) |
3.4 | 16.8 | GO:0032612 | interleukin-1 production(GO:0032612) |
3.3 | 3.3 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
3.3 | 6.6 | GO:0044033 | multi-organism metabolic process(GO:0044033) |
3.3 | 3.3 | GO:2000319 | regulation of T-helper 17 cell differentiation(GO:2000319) |
3.3 | 46.2 | GO:0015701 | bicarbonate transport(GO:0015701) |
3.3 | 214.4 | GO:0051301 | cell division(GO:0051301) |
3.3 | 23.0 | GO:0010498 | proteasomal protein catabolic process(GO:0010498) |
3.3 | 9.8 | GO:0014896 | muscle hypertrophy(GO:0014896) |
3.3 | 16.4 | GO:0001890 | placenta development(GO:0001890) |
3.3 | 6.5 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
3.3 | 45.5 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
3.2 | 32.5 | GO:0006270 | DNA replication initiation(GO:0006270) |
3.2 | 3.2 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
3.2 | 42.0 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
3.2 | 12.9 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
3.2 | 58.0 | GO:0031424 | keratinization(GO:0031424) |
3.2 | 9.7 | GO:0001659 | temperature homeostasis(GO:0001659) |
3.2 | 3.2 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
3.2 | 16.1 | GO:0048736 | appendage development(GO:0048736) limb development(GO:0060173) |
3.2 | 3.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
3.2 | 6.4 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
3.1 | 9.4 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
3.1 | 6.3 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
3.1 | 15.7 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
3.1 | 3.1 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
3.1 | 590.2 | GO:0006412 | translation(GO:0006412) |
3.1 | 12.5 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
3.1 | 37.2 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
3.1 | 6.2 | GO:0008209 | androgen metabolic process(GO:0008209) |
3.1 | 9.2 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
3.1 | 3.1 | GO:0033684 | regulation of luteinizing hormone secretion(GO:0033684) |
3.0 | 12.2 | GO:0060976 | coronary vasculature development(GO:0060976) |
3.0 | 121.3 | GO:0006281 | DNA repair(GO:0006281) |
3.0 | 15.0 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
3.0 | 6.0 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
3.0 | 3.0 | GO:0040016 | embryonic cleavage(GO:0040016) |
3.0 | 95.2 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
3.0 | 5.9 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
3.0 | 17.8 | GO:0070207 | protein homotrimerization(GO:0070207) |
3.0 | 5.9 | GO:0018126 | protein hydroxylation(GO:0018126) |
2.9 | 5.9 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
2.9 | 55.6 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
2.9 | 20.5 | GO:0098773 | skin epidermis development(GO:0098773) |
2.9 | 2.9 | GO:0014831 | gastro-intestinal system smooth muscle contraction(GO:0014831) |
2.9 | 5.8 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
2.9 | 8.7 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
2.9 | 14.4 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
2.9 | 17.2 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
2.9 | 5.7 | GO:0033762 | response to glucagon(GO:0033762) |
2.8 | 8.5 | GO:0043473 | pigmentation(GO:0043473) |
2.8 | 2.8 | GO:0016125 | sterol metabolic process(GO:0016125) |
2.8 | 2.8 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
2.8 | 2.8 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
2.8 | 359.5 | GO:0008380 | RNA splicing(GO:0008380) |
2.8 | 28.3 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
2.8 | 16.9 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
2.8 | 2.8 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
2.8 | 5.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
2.8 | 8.3 | GO:0034440 | fatty acid oxidation(GO:0019395) lipid oxidation(GO:0034440) |
2.8 | 5.6 | GO:0045777 | positive regulation of blood pressure(GO:0045777) |
2.8 | 2.8 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
2.8 | 19.3 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
2.8 | 8.3 | GO:0010829 | negative regulation of glucose transport(GO:0010829) negative regulation of glucose import(GO:0046325) |
2.7 | 22.0 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
2.7 | 11.0 | GO:0002347 | response to tumor cell(GO:0002347) |
2.7 | 8.2 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
2.7 | 2.7 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
2.7 | 8.2 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
2.7 | 2.7 | GO:0048066 | developmental pigmentation(GO:0048066) |
2.7 | 8.0 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
2.7 | 10.6 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
2.7 | 87.8 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
2.7 | 10.6 | GO:0090329 | regulation of DNA-dependent DNA replication(GO:0090329) |
2.6 | 41.8 | GO:0006956 | complement activation(GO:0006956) |
2.6 | 10.3 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
2.6 | 2.6 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
2.5 | 2.5 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
2.5 | 15.1 | GO:0070166 | enamel mineralization(GO:0070166) |
2.5 | 2.5 | GO:0046174 | polyol catabolic process(GO:0046174) |
2.5 | 2.5 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
2.5 | 34.7 | GO:0019835 | cytolysis(GO:0019835) |
2.4 | 9.7 | GO:0009615 | response to virus(GO:0009615) |
2.4 | 55.7 | GO:0008033 | tRNA processing(GO:0008033) |
2.4 | 2.4 | GO:0035270 | endocrine system development(GO:0035270) |
2.4 | 2.4 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
2.4 | 7.2 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
2.4 | 2.4 | GO:0001974 | blood vessel remodeling(GO:0001974) |
2.4 | 2.4 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
2.4 | 23.5 | GO:0050728 | negative regulation of inflammatory response(GO:0050728) |
2.3 | 21.0 | GO:0071453 | cellular response to oxygen levels(GO:0071453) |
2.3 | 6.9 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
2.3 | 108.5 | GO:0001701 | in utero embryonic development(GO:0001701) |
2.3 | 2.3 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
2.3 | 2.3 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
2.3 | 367.6 | GO:0048232 | male gamete generation(GO:0048232) |
2.3 | 22.9 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
2.3 | 2.3 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
2.3 | 6.8 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
2.3 | 4.5 | GO:0018394 | peptidyl-lysine acetylation(GO:0018394) |
2.3 | 9.0 | GO:0071435 | potassium ion export(GO:0071435) |
2.2 | 4.4 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
2.2 | 15.5 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
2.2 | 6.6 | GO:0034612 | response to tumor necrosis factor(GO:0034612) |
2.2 | 2.2 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
2.2 | 2.2 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
2.2 | 24.0 | GO:0006953 | acute-phase response(GO:0006953) |
2.2 | 6.5 | GO:0009988 | cell-cell recognition(GO:0009988) |
2.2 | 2.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
2.2 | 2.2 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
2.1 | 2.1 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
2.1 | 2.1 | GO:0035456 | response to interferon-beta(GO:0035456) |
2.1 | 49.3 | GO:0046777 | protein autophosphorylation(GO:0046777) |
2.1 | 6.4 | GO:0071466 | xenobiotic metabolic process(GO:0006805) cellular response to xenobiotic stimulus(GO:0071466) |
2.1 | 2.1 | GO:0043370 | regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043370) |
2.1 | 27.4 | GO:0030641 | regulation of cellular pH(GO:0030641) |
2.1 | 6.3 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
2.1 | 4.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
2.1 | 4.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
2.1 | 6.3 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
2.1 | 12.6 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
2.1 | 2.1 | GO:0090189 | regulation of branching involved in ureteric bud morphogenesis(GO:0090189) |
2.1 | 2.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
2.1 | 2.1 | GO:0032275 | luteinizing hormone secretion(GO:0032275) |
2.1 | 6.2 | GO:0097186 | amelogenesis(GO:0097186) |
2.1 | 2.1 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
2.1 | 8.2 | GO:0006465 | signal peptide processing(GO:0006465) |
2.0 | 20.5 | GO:0043406 | positive regulation of MAP kinase activity(GO:0043406) |
2.0 | 8.1 | GO:1902110 | positive regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902110) mitochondrial outer membrane permeabilization involved in programmed cell death(GO:1902686) |
2.0 | 8.1 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
2.0 | 12.0 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
2.0 | 82.0 | GO:0042384 | cilium assembly(GO:0042384) |
2.0 | 5.9 | GO:0045851 | pH reduction(GO:0045851) |
2.0 | 3.9 | GO:0030888 | regulation of B cell proliferation(GO:0030888) |
2.0 | 3.9 | GO:0006401 | RNA catabolic process(GO:0006401) |
1.9 | 11.6 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
1.9 | 5.8 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
1.9 | 1.9 | GO:0015791 | polyol transport(GO:0015791) |
1.9 | 3.8 | GO:0034505 | tooth mineralization(GO:0034505) |
1.9 | 7.6 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
1.9 | 22.7 | GO:0006006 | glucose metabolic process(GO:0006006) |
1.9 | 13.2 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
1.9 | 20.6 | GO:0071560 | cellular response to transforming growth factor beta stimulus(GO:0071560) |
1.9 | 1.9 | GO:0043276 | anoikis(GO:0043276) |
1.9 | 1.9 | GO:0006106 | fumarate metabolic process(GO:0006106) |
1.8 | 66.2 | GO:0070482 | response to oxygen levels(GO:0070482) |
1.8 | 7.3 | GO:0090100 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway(GO:0090100) |
1.8 | 3.7 | GO:0002507 | tolerance induction(GO:0002507) |
1.8 | 3.6 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
1.8 | 1.8 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
1.8 | 96.6 | GO:0051607 | defense response to virus(GO:0051607) |
1.8 | 5.4 | GO:0042255 | ribosome assembly(GO:0042255) |
1.8 | 122.8 | GO:0051346 | negative regulation of hydrolase activity(GO:0051346) |
1.8 | 63.8 | GO:0042060 | wound healing(GO:0042060) |
1.8 | 1.8 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
1.8 | 72.1 | GO:0071222 | cellular response to lipopolysaccharide(GO:0071222) |
1.7 | 1.7 | GO:0036093 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
1.7 | 1.7 | GO:0006826 | iron ion transport(GO:0006826) |
1.7 | 6.8 | GO:0006590 | thyroid hormone generation(GO:0006590) |
1.7 | 1.7 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
1.7 | 110.7 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
1.7 | 1.7 | GO:0015931 | nucleobase-containing compound transport(GO:0015931) |
1.7 | 13.3 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
1.7 | 1.7 | GO:0010658 | striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) |
1.6 | 1.6 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
1.6 | 1.6 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
1.6 | 1.6 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
1.6 | 11.4 | GO:0044782 | cilium organization(GO:0044782) |
1.6 | 3.3 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) |
1.6 | 144.1 | GO:0030163 | protein catabolic process(GO:0030163) |
1.6 | 4.8 | GO:0070995 | NADPH oxidation(GO:0070995) |
1.6 | 3.2 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
1.6 | 1.6 | GO:0006650 | glycerophospholipid metabolic process(GO:0006650) |
1.5 | 1.5 | GO:0009624 | response to nematode(GO:0009624) |
1.5 | 3.1 | GO:0030225 | macrophage differentiation(GO:0030225) |
1.5 | 3.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
1.5 | 1.5 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
1.5 | 13.5 | GO:0008089 | anterograde axonal transport(GO:0008089) |
1.5 | 16.5 | GO:0022900 | electron transport chain(GO:0022900) |
1.5 | 7.5 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
1.5 | 1.5 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
1.5 | 3.0 | GO:0044704 | single-organism reproductive behavior(GO:0044704) |
1.5 | 4.5 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
1.5 | 3.0 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
1.5 | 1.5 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
1.5 | 11.8 | GO:0072348 | sulfur compound transport(GO:0072348) |
1.4 | 2.9 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
1.4 | 10.0 | GO:0009060 | aerobic respiration(GO:0009060) |
1.4 | 2.9 | GO:0032094 | response to food(GO:0032094) |
1.4 | 1017.5 | GO:0006351 | transcription, DNA-templated(GO:0006351) |
1.4 | 1.4 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
1.4 | 4.1 | GO:0070231 | T cell apoptotic process(GO:0070231) |
1.4 | 8.2 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
1.4 | 1.4 | GO:0040029 | regulation of gene expression, epigenetic(GO:0040029) |
1.4 | 16.2 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
1.3 | 6.7 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
1.3 | 2.7 | GO:0001782 | B cell homeostasis(GO:0001782) |
1.3 | 10.6 | GO:0022613 | ribonucleoprotein complex biogenesis(GO:0022613) |
1.3 | 2.6 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
1.3 | 2.6 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
1.3 | 3.9 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
1.3 | 14.3 | GO:0007602 | phototransduction(GO:0007602) |
1.3 | 3.9 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
1.3 | 2.6 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
1.2 | 2.5 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
1.2 | 1.2 | GO:0045639 | positive regulation of myeloid cell differentiation(GO:0045639) |
1.2 | 3.6 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
1.2 | 1.2 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
1.2 | 1.2 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
1.2 | 1.2 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
1.2 | 3.5 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
1.1 | 3.4 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
1.1 | 4.5 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
1.1 | 12.3 | GO:0032496 | response to lipopolysaccharide(GO:0032496) |
1.1 | 2.2 | GO:0006739 | NADP metabolic process(GO:0006739) |
1.1 | 1.1 | GO:0015747 | urate transport(GO:0015747) |
1.1 | 6.3 | GO:0051205 | protein insertion into membrane(GO:0051205) |
1.0 | 2.1 | GO:0002580 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
1.0 | 3.1 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
1.0 | 7.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
1.0 | 1.0 | GO:0043589 | skin morphogenesis(GO:0043589) |
1.0 | 1.0 | GO:0051132 | NK T cell activation(GO:0051132) |
1.0 | 10.6 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
1.0 | 1.0 | GO:0009394 | 2'-deoxyribonucleotide metabolic process(GO:0009394) deoxyribose phosphate metabolic process(GO:0019692) |
1.0 | 1.0 | GO:0042107 | cytokine metabolic process(GO:0042107) |
1.0 | 1.0 | GO:0060022 | hard palate development(GO:0060022) |
0.9 | 2.8 | GO:0072091 | regulation of stem cell proliferation(GO:0072091) |
0.9 | 4.7 | GO:0070664 | negative regulation of leukocyte proliferation(GO:0070664) |
0.9 | 31.0 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.9 | 0.9 | GO:0033280 | response to vitamin D(GO:0033280) |
0.9 | 2.7 | GO:0043043 | peptide biosynthetic process(GO:0043043) |
0.9 | 2.7 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.9 | 17.8 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
0.9 | 52.2 | GO:0098542 | defense response to other organism(GO:0098542) |
0.9 | 0.9 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.9 | 0.9 | GO:0043455 | regulation of secondary metabolic process(GO:0043455) |
0.8 | 31.4 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.8 | 3.4 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.8 | 0.8 | GO:0052803 | histamine metabolic process(GO:0001692) imidazole-containing compound metabolic process(GO:0052803) |
0.8 | 2.5 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.8 | 1.7 | GO:0019695 | choline metabolic process(GO:0019695) |
0.8 | 0.8 | GO:0097193 | intrinsic apoptotic signaling pathway(GO:0097193) |
0.8 | 0.8 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.8 | 0.8 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.8 | 3.9 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.8 | 0.8 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.8 | 0.8 | GO:0031033 | myosin filament organization(GO:0031033) |
0.7 | 16.4 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.7 | 0.7 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.7 | 10.8 | GO:0045444 | fat cell differentiation(GO:0045444) |
0.7 | 2.9 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.7 | 0.7 | GO:0001562 | response to protozoan(GO:0001562) |
0.7 | 173.7 | GO:0006508 | proteolysis(GO:0006508) |
0.7 | 7.0 | GO:0042113 | B cell activation(GO:0042113) |
0.7 | 6.2 | GO:0017038 | protein import(GO:0017038) |
0.7 | 0.7 | GO:0071559 | response to transforming growth factor beta(GO:0071559) |
0.7 | 0.7 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.7 | 0.7 | GO:0002819 | regulation of adaptive immune response(GO:0002819) |
0.7 | 0.7 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.7 | 2.0 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.6 | 0.6 | GO:0046148 | pigment biosynthetic process(GO:0046148) |
0.6 | 3.2 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.6 | 0.6 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.6 | 0.6 | GO:0002285 | lymphocyte activation involved in immune response(GO:0002285) |
0.6 | 0.6 | GO:0016445 | somatic diversification of immunoglobulins(GO:0016445) |
0.6 | 3.0 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.6 | 0.6 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.6 | 1.2 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.6 | 17.9 | GO:0006396 | RNA processing(GO:0006396) |
0.6 | 0.6 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.5 | 0.5 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.5 | 0.5 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.5 | 2.1 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.5 | 98.8 | GO:0055114 | oxidation-reduction process(GO:0055114) |
0.5 | 0.5 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.5 | 18.4 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.5 | 3.0 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.5 | 0.9 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.5 | 3.2 | GO:0035303 | regulation of dephosphorylation(GO:0035303) |
0.5 | 0.5 | GO:0007369 | gastrulation(GO:0007369) |
0.4 | 2.2 | GO:0003341 | cilium movement(GO:0003341) |
0.4 | 0.4 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.4 | 0.9 | GO:0006265 | DNA topological change(GO:0006265) |
0.4 | 0.4 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.4 | 0.4 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.4 | 0.4 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.4 | 1.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.4 | 0.4 | GO:0009620 | response to fungus(GO:0009620) |
0.4 | 0.8 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.4 | 0.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.4 | 0.7 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.4 | 1.4 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.4 | 12.4 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.3 | 0.3 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) |
0.3 | 0.6 | GO:0071496 | cellular response to external stimulus(GO:0071496) |
0.3 | 0.3 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.3 | 0.9 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.3 | 0.3 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.3 | 0.6 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.3 | 1.7 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.3 | 0.3 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.3 | 0.5 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
0.2 | 3.7 | GO:0010629 | negative regulation of gene expression(GO:0010629) |
0.2 | 0.5 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.2 | 0.2 | GO:0033032 | regulation of myeloid cell apoptotic process(GO:0033032) |
0.2 | 0.2 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.1 | 0.1 | GO:0032528 | microvillus organization(GO:0032528) |
0.1 | 32.2 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.1 | 1.5 | GO:0019439 | aromatic compound catabolic process(GO:0019439) |
0.1 | 0.4 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.1 | 0.1 | GO:0032252 | secretory granule localization(GO:0032252) |
0.1 | 11.4 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.1 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.1 | 0.1 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.1 | 0.3 | GO:0055006 | cardiac cell development(GO:0055006) |
0.1 | 0.1 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.0 | GO:0060179 | male mating behavior(GO:0060179) |
0.0 | 0.4 | GO:0051253 | negative regulation of RNA metabolic process(GO:0051253) |
0.0 | 0.3 | GO:1901657 | glycosyl compound metabolic process(GO:1901657) |
0.0 | 0.0 | GO:0042633 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
54.2 | 162.6 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
46.2 | 277.0 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
45.2 | 180.9 | GO:0072487 | MSL complex(GO:0072487) |
41.0 | 205.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
39.4 | 197.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
37.8 | 151.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
37.5 | 187.5 | GO:0005638 | lamin filament(GO:0005638) |
36.3 | 254.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
34.5 | 103.6 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
33.9 | 135.7 | GO:0035363 | histone locus body(GO:0035363) |
33.5 | 100.5 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
32.3 | 129.1 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
30.9 | 92.7 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
30.4 | 121.5 | GO:0031094 | platelet dense tubular network(GO:0031094) |
30.2 | 120.8 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
29.7 | 178.3 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
28.5 | 85.6 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
28.1 | 140.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
28.1 | 112.4 | GO:0071141 | SMAD protein complex(GO:0071141) |
27.9 | 83.7 | GO:0031523 | Myb complex(GO:0031523) |
27.2 | 54.4 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
26.8 | 107.3 | GO:1990204 | oxidoreductase complex(GO:1990204) |
26.7 | 80.1 | GO:0043293 | apoptosome(GO:0043293) |
26.7 | 213.4 | GO:0030056 | hemidesmosome(GO:0030056) |
26.3 | 105.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
26.0 | 26.0 | GO:0005914 | spot adherens junction(GO:0005914) |
25.5 | 101.8 | GO:0042825 | TAP complex(GO:0042825) |
25.4 | 101.8 | GO:0005642 | annulate lamellae(GO:0005642) |
25.3 | 1520.4 | GO:0000118 | histone deacetylase complex(GO:0000118) |
25.0 | 174.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
24.3 | 24.3 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
24.3 | 97.1 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
24.0 | 144.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
23.9 | 358.1 | GO:0000421 | autophagosome membrane(GO:0000421) |
23.8 | 71.4 | GO:0097451 | glial limiting end-foot(GO:0097451) |
23.6 | 212.0 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
23.4 | 210.2 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
23.2 | 92.8 | GO:0097524 | sperm plasma membrane(GO:0097524) |
23.0 | 207.3 | GO:0031010 | ISWI-type complex(GO:0031010) |
23.0 | 160.7 | GO:0070688 | MLL5-L complex(GO:0070688) |
22.9 | 228.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
22.5 | 67.5 | GO:0032127 | dense core granule membrane(GO:0032127) |
22.4 | 156.7 | GO:0005677 | chromatin silencing complex(GO:0005677) |
22.3 | 111.7 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
22.3 | 111.3 | GO:0097470 | ribbon synapse(GO:0097470) |
22.0 | 22.0 | GO:0036449 | microtubule minus-end(GO:0036449) |
21.8 | 240.3 | GO:0035102 | PRC1 complex(GO:0035102) |
21.8 | 174.6 | GO:0001650 | fibrillar center(GO:0001650) |
21.8 | 283.6 | GO:0031528 | microvillus membrane(GO:0031528) |
21.7 | 281.9 | GO:0016514 | SWI/SNF complex(GO:0016514) |
21.7 | 21.7 | GO:0097512 | cardiac myofibril(GO:0097512) |
21.4 | 214.2 | GO:0070938 | contractile ring(GO:0070938) |
21.1 | 63.2 | GO:0097443 | sorting endosome(GO:0097443) |
20.3 | 60.9 | GO:0097413 | Lewy body(GO:0097413) |
20.1 | 180.5 | GO:0090544 | BAF-type complex(GO:0090544) |
20.0 | 59.9 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
19.9 | 159.4 | GO:0001939 | female pronucleus(GO:0001939) |
19.9 | 79.4 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
19.7 | 137.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
19.7 | 59.0 | GO:0043259 | laminin-10 complex(GO:0043259) |
19.4 | 58.1 | GO:0000811 | GINS complex(GO:0000811) |
19.4 | 58.1 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
19.3 | 154.6 | GO:0016600 | flotillin complex(GO:0016600) |
19.3 | 38.6 | GO:0000322 | storage vacuole(GO:0000322) |
19.2 | 57.5 | GO:0000235 | astral microtubule(GO:0000235) |
19.1 | 57.3 | GO:0005745 | m-AAA complex(GO:0005745) |
18.9 | 283.5 | GO:0031519 | PcG protein complex(GO:0031519) |
18.5 | 74.1 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
18.4 | 91.8 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
18.1 | 54.3 | GO:1990357 | terminal web(GO:1990357) |
18.0 | 18.0 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
17.5 | 175.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
17.5 | 70.1 | GO:0030689 | Noc complex(GO:0030689) |
17.4 | 17.4 | GO:0016939 | kinesin II complex(GO:0016939) |
17.4 | 34.7 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
17.3 | 500.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
17.2 | 258.4 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
17.2 | 51.5 | GO:0099738 | cell cortex region(GO:0099738) |
17.1 | 51.4 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
17.1 | 85.3 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
17.0 | 118.9 | GO:0000788 | nuclear nucleosome(GO:0000788) |
16.9 | 84.7 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
16.9 | 16.9 | GO:1990423 | RZZ complex(GO:1990423) |
16.7 | 16.7 | GO:0032587 | ruffle membrane(GO:0032587) |
16.7 | 66.6 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
16.6 | 49.7 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
16.6 | 16.6 | GO:0044292 | dendrite terminus(GO:0044292) |
16.4 | 131.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
16.4 | 16.4 | GO:0005818 | aster(GO:0005818) |
16.4 | 114.5 | GO:0042382 | paraspeckles(GO:0042382) |
16.4 | 32.7 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
16.3 | 130.6 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
16.3 | 65.0 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
16.2 | 48.6 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
16.2 | 80.9 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
16.1 | 64.5 | GO:0071203 | WASH complex(GO:0071203) |
16.0 | 64.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
16.0 | 48.1 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
16.0 | 159.6 | GO:0097539 | ciliary transition fiber(GO:0097539) |
15.9 | 111.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
15.9 | 669.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
15.9 | 47.7 | GO:0031084 | BLOC-2 complex(GO:0031084) |
15.9 | 47.7 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
15.8 | 47.5 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
15.7 | 94.3 | GO:0090543 | Flemming body(GO:0090543) |
15.7 | 125.7 | GO:0042641 | actomyosin(GO:0042641) |
15.7 | 251.0 | GO:0002102 | podosome(GO:0002102) |
15.7 | 814.8 | GO:0032432 | actin filament bundle(GO:0032432) |
15.7 | 31.3 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
15.6 | 46.8 | GO:0005955 | calcineurin complex(GO:0005955) |
15.6 | 62.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
15.6 | 46.7 | GO:0097452 | GAIT complex(GO:0097452) |
15.4 | 46.3 | GO:0035061 | interchromatin granule(GO:0035061) |
15.4 | 15.4 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
15.3 | 122.3 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
15.3 | 198.5 | GO:0030914 | STAGA complex(GO:0030914) |
15.2 | 45.6 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
15.1 | 438.8 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
15.0 | 45.0 | GO:0005828 | kinetochore microtubule(GO:0005828) |
15.0 | 119.8 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
14.8 | 59.3 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
14.7 | 191.1 | GO:0038201 | TOR complex(GO:0038201) |
14.7 | 58.7 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
14.6 | 204.9 | GO:0000786 | nucleosome(GO:0000786) |
14.6 | 43.7 | GO:0005915 | zonula adherens(GO:0005915) |
14.5 | 145.0 | GO:0097431 | mitotic spindle pole(GO:0097431) |
14.4 | 72.2 | GO:0070820 | tertiary granule(GO:0070820) |
14.3 | 43.0 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
14.3 | 14.3 | GO:0000439 | core TFIIH complex(GO:0000439) |
14.3 | 114.1 | GO:0070578 | RISC-loading complex(GO:0070578) |
14.2 | 156.3 | GO:0032039 | integrator complex(GO:0032039) |
14.2 | 170.2 | GO:0097440 | apical dendrite(GO:0097440) |
14.2 | 14.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
14.2 | 42.5 | GO:0031417 | NatC complex(GO:0031417) |
14.1 | 28.3 | GO:0005879 | axonemal microtubule(GO:0005879) |
14.1 | 84.6 | GO:0031415 | NatA complex(GO:0031415) |
14.0 | 70.1 | GO:0005916 | fascia adherens(GO:0005916) |
14.0 | 280.0 | GO:0035145 | exon-exon junction complex(GO:0035145) |
14.0 | 14.0 | GO:0030175 | filopodium(GO:0030175) |
14.0 | 14.0 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
13.9 | 41.6 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
13.7 | 54.6 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
13.5 | 661.3 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
13.4 | 793.4 | GO:0016363 | nuclear matrix(GO:0016363) |
13.4 | 53.8 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
13.4 | 26.9 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
13.4 | 134.2 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
13.3 | 26.7 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
13.2 | 185.2 | GO:0005719 | nuclear euchromatin(GO:0005719) |
13.2 | 52.7 | GO:0015629 | actin cytoskeleton(GO:0015629) |
13.1 | 39.4 | GO:0097149 | centralspindlin complex(GO:0097149) |
13.1 | 39.3 | GO:1990462 | omegasome(GO:1990462) |
13.1 | 248.6 | GO:0071010 | prespliceosome(GO:0071010) |
13.1 | 91.4 | GO:0034709 | methylosome(GO:0034709) |
13.1 | 26.1 | GO:0098536 | deuterosome(GO:0098536) |
13.0 | 26.1 | GO:1990923 | PET complex(GO:1990923) |
13.0 | 13.0 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
12.9 | 129.3 | GO:0010369 | chromocenter(GO:0010369) |
12.9 | 51.6 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
12.9 | 38.6 | GO:0071817 | MMXD complex(GO:0071817) |
12.8 | 320.6 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
12.8 | 25.5 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
12.8 | 114.8 | GO:0031143 | pseudopodium(GO:0031143) |
12.7 | 38.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
12.7 | 38.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
12.7 | 89.0 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
12.7 | 266.7 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
12.7 | 63.4 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
12.7 | 658.7 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
12.7 | 215.1 | GO:0000242 | pericentriolar material(GO:0000242) |
12.6 | 50.5 | GO:0044194 | cytolytic granule(GO:0044194) |
12.6 | 25.3 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
12.6 | 201.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
12.5 | 87.6 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
12.5 | 87.3 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
12.4 | 74.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
12.4 | 99.1 | GO:0045120 | pronucleus(GO:0045120) |
12.4 | 37.1 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
12.4 | 74.2 | GO:0042587 | glycogen granule(GO:0042587) |
12.3 | 24.7 | GO:0042405 | nuclear inclusion body(GO:0042405) |
12.3 | 73.7 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
12.2 | 73.3 | GO:0097542 | ciliary tip(GO:0097542) |
12.2 | 3214.6 | GO:0005925 | focal adhesion(GO:0005925) |
12.1 | 301.9 | GO:0016592 | mediator complex(GO:0016592) |
12.1 | 555.2 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
12.1 | 84.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
12.0 | 636.5 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
11.9 | 178.3 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
11.9 | 71.2 | GO:0044666 | MLL3/4 complex(GO:0044666) |
11.9 | 213.5 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
11.8 | 82.6 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
11.8 | 35.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
11.7 | 11.7 | GO:0000346 | transcription export complex(GO:0000346) |
11.7 | 11.7 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
11.6 | 23.3 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
11.6 | 58.2 | GO:0035861 | site of double-strand break(GO:0035861) |
11.6 | 174.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
11.6 | 23.2 | GO:0005770 | late endosome(GO:0005770) |
11.5 | 11.5 | GO:0044327 | dendritic spine head(GO:0044327) |
11.5 | 34.6 | GO:0005588 | collagen type V trimer(GO:0005588) |
11.5 | 68.9 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
11.5 | 91.8 | GO:0005640 | nuclear outer membrane(GO:0005640) |
11.4 | 11.4 | GO:0042585 | germinal vesicle(GO:0042585) |
11.4 | 79.7 | GO:0044232 | organelle membrane contact site(GO:0044232) |
11.4 | 113.8 | GO:0035631 | CD40 receptor complex(GO:0035631) |
11.3 | 79.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
11.3 | 45.3 | GO:0033269 | internode region of axon(GO:0033269) |
11.3 | 565.5 | GO:0005811 | lipid particle(GO:0005811) |
11.3 | 45.1 | GO:0044294 | dendritic growth cone(GO:0044294) |
11.3 | 112.7 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
11.3 | 67.6 | GO:0031512 | motile primary cilium(GO:0031512) |
11.2 | 67.5 | GO:0005682 | U5 snRNP(GO:0005682) |
11.2 | 22.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
11.2 | 22.4 | GO:0097342 | ripoptosome(GO:0097342) |
11.2 | 44.7 | GO:0044815 | DNA packaging complex(GO:0044815) |
11.2 | 33.5 | GO:1990130 | Iml1 complex(GO:1990130) |
11.1 | 77.6 | GO:0070652 | HAUS complex(GO:0070652) |
11.1 | 66.4 | GO:0031209 | SCAR complex(GO:0031209) |
11.0 | 132.0 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
11.0 | 241.1 | GO:0012505 | endomembrane system(GO:0012505) |
10.9 | 54.6 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
10.9 | 87.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
10.8 | 325.0 | GO:0005776 | autophagosome(GO:0005776) |
10.8 | 64.9 | GO:0005796 | Golgi lumen(GO:0005796) |
10.8 | 32.4 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
10.8 | 97.0 | GO:0070852 | cell body fiber(GO:0070852) |
10.8 | 107.5 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
10.7 | 32.0 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
10.7 | 53.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
10.6 | 202.0 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
10.6 | 127.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
10.5 | 42.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
10.4 | 188.0 | GO:0042588 | zymogen granule(GO:0042588) |
10.4 | 114.9 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
10.4 | 104.3 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
10.4 | 31.1 | GO:0072687 | meiotic spindle(GO:0072687) |
10.4 | 498.1 | GO:0016605 | PML body(GO:0016605) |
10.4 | 20.7 | GO:0005871 | kinesin complex(GO:0005871) |
10.4 | 1180.6 | GO:0000790 | nuclear chromatin(GO:0000790) |
10.3 | 10.3 | GO:0030891 | VCB complex(GO:0030891) |
10.3 | 247.0 | GO:0005876 | spindle microtubule(GO:0005876) |
10.3 | 30.9 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
10.3 | 30.8 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
10.2 | 71.5 | GO:0097208 | alveolar lamellar body(GO:0097208) |
10.2 | 40.8 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
10.2 | 71.3 | GO:0035859 | Seh1-associated complex(GO:0035859) |
10.2 | 91.5 | GO:0036128 | CatSper complex(GO:0036128) |
10.2 | 20.3 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
10.1 | 20.2 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
10.0 | 110.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
10.0 | 30.0 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
10.0 | 20.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
9.9 | 29.8 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
9.9 | 266.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
9.9 | 108.7 | GO:0051233 | spindle midzone(GO:0051233) |
9.8 | 78.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
9.8 | 9.8 | GO:0031902 | late endosome membrane(GO:0031902) |
9.8 | 9.8 | GO:0097422 | tubular endosome(GO:0097422) |
9.8 | 48.8 | GO:0045179 | apical cortex(GO:0045179) |
9.8 | 107.4 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
9.7 | 9.7 | GO:0061574 | ASAP complex(GO:0061574) |
9.6 | 67.4 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
9.6 | 11740.7 | GO:0005654 | nucleoplasm(GO:0005654) |
9.6 | 458.7 | GO:0044439 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
9.5 | 76.0 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
9.5 | 28.4 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
9.4 | 37.6 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
9.4 | 188.0 | GO:0000785 | chromatin(GO:0000785) |
9.3 | 84.0 | GO:1902554 | serine/threonine protein kinase complex(GO:1902554) |
9.3 | 65.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
9.3 | 18.5 | GO:0000814 | ESCRT II complex(GO:0000814) |
9.3 | 9.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
9.2 | 129.4 | GO:0005605 | basal lamina(GO:0005605) |
9.2 | 202.0 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
9.2 | 27.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
9.1 | 27.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
9.1 | 27.3 | GO:0071953 | elastic fiber(GO:0071953) |
9.1 | 9.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
9.1 | 126.8 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
9.0 | 27.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
9.0 | 126.2 | GO:0030904 | retromer complex(GO:0030904) |
9.0 | 35.9 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
9.0 | 53.9 | GO:0042599 | lamellar body(GO:0042599) |
8.9 | 62.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
8.9 | 17.8 | GO:0005577 | fibrinogen complex(GO:0005577) |
8.9 | 825.9 | GO:0031965 | nuclear membrane(GO:0031965) |
8.8 | 35.3 | GO:0043601 | nuclear replisome(GO:0043601) |
8.8 | 227.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
8.7 | 391.6 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
8.7 | 156.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
8.7 | 147.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
8.6 | 1053.0 | GO:0005667 | transcription factor complex(GO:0005667) |
8.6 | 17.3 | GO:0034399 | nuclear periphery(GO:0034399) |
8.6 | 17.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
8.5 | 238.8 | GO:0016459 | myosin complex(GO:0016459) |
8.5 | 127.9 | GO:0055038 | recycling endosome membrane(GO:0055038) |
8.5 | 50.9 | GO:0034464 | BBSome(GO:0034464) |
8.5 | 110.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
8.5 | 59.3 | GO:0005861 | troponin complex(GO:0005861) |
8.5 | 84.6 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
8.4 | 125.7 | GO:0097228 | sperm principal piece(GO:0097228) |
8.3 | 66.6 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
8.3 | 24.9 | GO:0089701 | U2AF(GO:0089701) |
8.3 | 83.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
8.3 | 8.3 | GO:0042827 | platelet dense granule(GO:0042827) |
8.3 | 58.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
8.3 | 414.7 | GO:0030139 | endocytic vesicle(GO:0030139) |
8.2 | 73.7 | GO:0001891 | phagocytic cup(GO:0001891) |
8.1 | 24.4 | GO:0071439 | clathrin complex(GO:0071439) |
8.0 | 32.0 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
8.0 | 16.0 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
8.0 | 23.9 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
7.9 | 7.9 | GO:0044316 | cone cell pedicle(GO:0044316) |
7.8 | 54.8 | GO:0033263 | CORVET complex(GO:0033263) |
7.8 | 85.8 | GO:0009925 | basal plasma membrane(GO:0009925) |
7.8 | 15.6 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
7.7 | 38.7 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
7.7 | 208.6 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
7.7 | 7.7 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
7.7 | 138.3 | GO:0001772 | immunological synapse(GO:0001772) |
7.7 | 7.7 | GO:0032585 | multivesicular body membrane(GO:0032585) |
7.7 | 7.7 | GO:0043219 | lateral loop(GO:0043219) |
7.6 | 7.6 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
7.6 | 296.1 | GO:0005902 | microvillus(GO:0005902) |
7.5 | 98.0 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
7.5 | 22.6 | GO:0031090 | organelle membrane(GO:0031090) |
7.5 | 30.0 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
7.4 | 7.4 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
7.4 | 717.5 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
7.4 | 29.5 | GO:0036452 | ESCRT complex(GO:0036452) |
7.4 | 22.1 | GO:0042583 | chromaffin granule(GO:0042583) |
7.4 | 22.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
7.3 | 95.4 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
7.2 | 21.7 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
7.2 | 57.9 | GO:0031211 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
7.2 | 187.8 | GO:0030496 | midbody(GO:0030496) |
7.1 | 56.8 | GO:0017119 | Golgi transport complex(GO:0017119) |
7.1 | 191.3 | GO:0005844 | polysome(GO:0005844) |
7.1 | 42.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
7.1 | 105.8 | GO:0034451 | centriolar satellite(GO:0034451) |
7.0 | 14.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
7.0 | 7.0 | GO:0071437 | invadopodium(GO:0071437) |
7.0 | 174.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
6.9 | 20.8 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
6.9 | 6.9 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
6.9 | 249.2 | GO:0000502 | proteasome complex(GO:0000502) |
6.9 | 41.5 | GO:0010008 | endosome membrane(GO:0010008) |
6.8 | 143.5 | GO:0055037 | recycling endosome(GO:0055037) |
6.8 | 6.8 | GO:0033270 | paranode region of axon(GO:0033270) |
6.8 | 345.0 | GO:0005938 | cell cortex(GO:0005938) |
6.8 | 1128.2 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
6.7 | 6.7 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
6.7 | 268.5 | GO:0005795 | Golgi stack(GO:0005795) |
6.7 | 13.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
6.7 | 13.4 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
6.7 | 6.7 | GO:0005686 | U2 snRNP(GO:0005686) |
6.6 | 6.6 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
6.6 | 2077.8 | GO:0005730 | nucleolus(GO:0005730) |
6.6 | 19.8 | GO:0071797 | LUBAC complex(GO:0071797) |
6.6 | 72.3 | GO:0008305 | integrin complex(GO:0008305) |
6.6 | 46.0 | GO:0030667 | secretory granule membrane(GO:0030667) |
6.6 | 13.1 | GO:0000243 | commitment complex(GO:0000243) |
6.5 | 19.4 | GO:0030055 | cell-substrate junction(GO:0030055) |
6.4 | 58.0 | GO:0030663 | COPI vesicle coat(GO:0030126) COPI-coated vesicle membrane(GO:0030663) |
6.4 | 206.3 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
6.4 | 25.8 | GO:0000938 | GARP complex(GO:0000938) |
6.3 | 6.3 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
6.3 | 125.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
6.3 | 12.5 | GO:0046930 | pore complex(GO:0046930) |
6.2 | 6.2 | GO:0002141 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) |
6.2 | 37.5 | GO:0097225 | sperm midpiece(GO:0097225) |
6.2 | 6.2 | GO:0016272 | prefoldin complex(GO:0016272) |
6.2 | 24.9 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
6.2 | 55.9 | GO:0036379 | myofilament(GO:0036379) |
6.2 | 4521.4 | GO:0005829 | cytosol(GO:0005829) |
6.2 | 24.7 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
6.1 | 18.4 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
6.1 | 12.2 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
6.1 | 60.5 | GO:0005657 | replication fork(GO:0005657) |
6.0 | 66.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
6.0 | 12.0 | GO:1990391 | DNA repair complex(GO:1990391) |
6.0 | 29.9 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
5.9 | 23.8 | GO:0032591 | dendritic spine membrane(GO:0032591) |
5.9 | 17.7 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
5.8 | 325.7 | GO:0005681 | spliceosomal complex(GO:0005681) |
5.8 | 260.6 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
5.7 | 11.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
5.7 | 5.7 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
5.7 | 34.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
5.7 | 279.5 | GO:0005903 | brush border(GO:0005903) |
5.7 | 11.4 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
5.6 | 16.8 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
5.6 | 5.6 | GO:0016342 | catenin complex(GO:0016342) |
5.5 | 355.3 | GO:0072562 | blood microparticle(GO:0072562) |
5.4 | 16.3 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
5.4 | 136.1 | GO:0031514 | motile cilium(GO:0031514) |
5.4 | 304.3 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
5.4 | 6444.9 | GO:0070062 | extracellular exosome(GO:0070062) |
5.4 | 118.6 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
5.3 | 352.9 | GO:0005815 | microtubule organizing center(GO:0005815) |
5.3 | 181.8 | GO:0005814 | centriole(GO:0005814) |
5.3 | 555.5 | GO:0005694 | chromosome(GO:0005694) |
5.2 | 522.3 | GO:0070013 | intracellular organelle lumen(GO:0070013) |
5.2 | 1026.4 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
5.1 | 35.8 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
5.1 | 10.2 | GO:0042555 | MCM complex(GO:0042555) |
5.1 | 25.4 | GO:0036157 | outer dynein arm(GO:0036157) |
5.1 | 207.5 | GO:0005769 | early endosome(GO:0005769) |
5.0 | 2110.9 | GO:0005739 | mitochondrion(GO:0005739) |
5.0 | 5.0 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
4.9 | 34.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
4.9 | 63.4 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
4.9 | 53.5 | GO:0000922 | spindle pole(GO:0000922) |
4.9 | 9118.7 | GO:0005634 | nucleus(GO:0005634) |
4.9 | 4.9 | GO:0097255 | R2TP complex(GO:0097255) |
4.8 | 14.5 | GO:0044853 | plasma membrane raft(GO:0044853) |
4.7 | 9.4 | GO:0045098 | type III intermediate filament(GO:0045098) |
4.5 | 18.1 | GO:0016234 | inclusion body(GO:0016234) |
4.4 | 13.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
4.4 | 4.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
4.2 | 4.2 | GO:0044440 | endosomal part(GO:0044440) |
4.2 | 12.6 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
4.1 | 240.3 | GO:0005874 | microtubule(GO:0005874) |
4.1 | 12.2 | GO:0046691 | intracellular canaliculus(GO:0046691) |
4.0 | 4.0 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
3.9 | 3.9 | GO:0016528 | sarcoplasm(GO:0016528) |
3.8 | 103.3 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
3.8 | 15.1 | GO:0043218 | compact myelin(GO:0043218) |
3.4 | 75.5 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
3.3 | 1688.5 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
3.2 | 6.4 | GO:0097546 | ciliary base(GO:0097546) |
3.2 | 6.3 | GO:0005774 | vacuolar membrane(GO:0005774) |
3.1 | 83.6 | GO:0043231 | intracellular membrane-bounded organelle(GO:0043231) |
3.0 | 80.9 | GO:0031984 | organelle subcompartment(GO:0031984) Golgi subcompartment(GO:0098791) |
3.0 | 8.9 | GO:0098858 | actin-based cell projection(GO:0098858) |
3.0 | 6.0 | GO:0005771 | multivesicular body(GO:0005771) |
3.0 | 98.0 | GO:0045177 | apical part of cell(GO:0045177) |
2.9 | 17.6 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
2.8 | 8.5 | GO:0032426 | stereocilium tip(GO:0032426) |
2.8 | 2.8 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
2.8 | 64.9 | GO:0070160 | occluding junction(GO:0070160) |
2.8 | 49.7 | GO:0045095 | keratin filament(GO:0045095) |
2.7 | 2.7 | GO:1990716 | axonemal central apparatus(GO:1990716) |
2.7 | 2.7 | GO:0070695 | FHF complex(GO:0070695) |
2.7 | 344.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
2.6 | 2.6 | GO:0045171 | intercellular bridge(GO:0045171) |
2.5 | 20.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
2.5 | 17.5 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
2.5 | 2.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
2.4 | 3541.3 | GO:0005737 | cytoplasm(GO:0005737) |
2.2 | 45.4 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
2.2 | 36.6 | GO:0005604 | basement membrane(GO:0005604) |
2.1 | 2.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
1.8 | 176.8 | GO:0030529 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
1.7 | 1.7 | GO:0042613 | MHC class II protein complex(GO:0042613) |
1.4 | 1.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
1.3 | 3.8 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.8 | 8.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.7 | 266.8 | GO:0005615 | extracellular space(GO:0005615) |
0.4 | 166.6 | GO:0005576 | extracellular region(GO:0005576) |
0.1 | 0.1 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.0 | GO:0001533 | cornified envelope(GO:0001533) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
64.8 | 64.8 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
55.6 | 166.9 | GO:0070644 | vitamin D response element binding(GO:0070644) |
54.2 | 216.6 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
53.1 | 159.4 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
51.1 | 204.3 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
50.3 | 150.9 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
46.6 | 279.6 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
43.5 | 130.6 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
43.3 | 129.9 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
41.2 | 164.8 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
40.8 | 40.8 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
40.2 | 281.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
39.2 | 196.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
39.1 | 117.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
35.2 | 35.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
33.5 | 267.9 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
33.4 | 133.7 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
33.3 | 33.3 | GO:0016420 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
33.2 | 99.6 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
33.2 | 697.0 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
32.8 | 295.4 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
32.1 | 32.1 | GO:0035174 | histone serine kinase activity(GO:0035174) |
31.8 | 127.4 | GO:0009374 | biotin binding(GO:0009374) |
31.3 | 94.0 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
31.0 | 93.0 | GO:1990188 | euchromatin binding(GO:1990188) |
30.3 | 90.8 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
30.0 | 90.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
30.0 | 60.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
29.8 | 29.8 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
29.6 | 29.6 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
28.4 | 113.5 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
28.3 | 28.3 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
27.9 | 83.7 | GO:0050692 | DBD domain binding(GO:0050692) |
27.7 | 138.7 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
27.6 | 82.9 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
27.6 | 165.6 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
27.1 | 108.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
26.7 | 320.9 | GO:0017166 | vinculin binding(GO:0017166) |
26.6 | 239.5 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
26.4 | 290.6 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
26.3 | 78.9 | GO:0004359 | glutaminase activity(GO:0004359) |
26.0 | 130.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
26.0 | 103.8 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
25.7 | 102.9 | GO:0042731 | PH domain binding(GO:0042731) |
25.6 | 76.7 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
25.5 | 101.9 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
25.5 | 305.5 | GO:0044548 | S100 protein binding(GO:0044548) |
25.2 | 75.7 | GO:0048030 | disaccharide binding(GO:0048030) |
25.2 | 201.6 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
25.1 | 100.3 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
25.0 | 25.0 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
24.9 | 124.6 | GO:0051525 | NFAT protein binding(GO:0051525) |
24.6 | 49.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
24.5 | 98.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
24.4 | 97.7 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
24.4 | 73.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
24.1 | 24.1 | GO:0050693 | LBD domain binding(GO:0050693) |
23.8 | 71.3 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
23.8 | 71.3 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
23.8 | 95.0 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
23.6 | 94.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
23.5 | 70.4 | GO:0070410 | co-SMAD binding(GO:0070410) |
23.4 | 70.3 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
23.4 | 281.0 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
23.3 | 70.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
23.3 | 139.9 | GO:0001727 | lipid kinase activity(GO:0001727) |
23.3 | 69.9 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
22.9 | 389.4 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
22.8 | 114.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
22.6 | 90.6 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
22.6 | 294.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
22.6 | 90.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
22.6 | 67.7 | GO:0019961 | interferon binding(GO:0019961) |
22.5 | 112.3 | GO:1990239 | steroid hormone binding(GO:1990239) |
22.4 | 67.3 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
22.4 | 112.0 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
22.4 | 672.1 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
21.9 | 43.8 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
21.5 | 64.6 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
21.5 | 258.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
21.5 | 21.5 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
21.4 | 107.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
21.4 | 299.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
21.4 | 42.7 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
21.3 | 85.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
21.3 | 191.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
21.3 | 85.1 | GO:0031720 | haptoglobin binding(GO:0031720) |
21.2 | 85.0 | GO:1990715 | mRNA CDS binding(GO:1990715) |
21.2 | 297.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
21.2 | 84.7 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
21.0 | 84.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
20.9 | 104.6 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
20.9 | 208.7 | GO:0048185 | activin binding(GO:0048185) |
20.7 | 103.3 | GO:0070061 | fructose binding(GO:0070061) |
20.5 | 472.0 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
20.5 | 225.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
20.3 | 40.5 | GO:0030519 | snoRNP binding(GO:0030519) |
20.2 | 181.9 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
20.2 | 40.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
20.1 | 60.2 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
20.0 | 140.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
19.9 | 259.0 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
19.9 | 218.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
19.9 | 79.4 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
19.8 | 19.8 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
19.8 | 79.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
19.6 | 58.9 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
19.6 | 117.3 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
19.5 | 58.6 | GO:0061665 | SUMO ligase activity(GO:0061665) |
19.5 | 78.0 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
19.5 | 175.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
19.4 | 116.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
19.4 | 252.1 | GO:0008143 | poly(A) binding(GO:0008143) |
19.4 | 58.2 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
19.4 | 232.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
19.3 | 38.6 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
19.2 | 96.2 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
19.2 | 57.5 | GO:0055100 | adiponectin binding(GO:0055100) |
18.9 | 94.7 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
18.9 | 75.8 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
18.7 | 74.9 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
18.7 | 74.8 | GO:0042015 | interleukin-20 binding(GO:0042015) |
18.7 | 243.0 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
18.6 | 93.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
18.6 | 18.6 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
18.6 | 74.3 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
18.5 | 129.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
18.5 | 55.4 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
18.4 | 55.3 | GO:0031491 | nucleosome binding(GO:0031491) |
18.4 | 92.1 | GO:0017040 | ceramidase activity(GO:0017040) |
18.4 | 18.4 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
18.4 | 257.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
18.3 | 91.5 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
18.2 | 36.5 | GO:0070878 | primary miRNA binding(GO:0070878) |
18.2 | 54.7 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
18.2 | 127.7 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
18.2 | 54.7 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
18.0 | 415.1 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
18.0 | 54.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
18.0 | 288.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
18.0 | 126.0 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
18.0 | 71.9 | GO:0002060 | purine nucleobase binding(GO:0002060) |
17.9 | 125.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
17.9 | 357.6 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
17.9 | 71.4 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
17.8 | 35.6 | GO:0030911 | TPR domain binding(GO:0030911) |
17.8 | 17.8 | GO:0051434 | BH3 domain binding(GO:0051434) |
17.7 | 106.4 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
17.6 | 17.6 | GO:0043426 | MRF binding(GO:0043426) |
17.5 | 87.5 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
17.5 | 69.9 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
17.5 | 52.4 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
17.3 | 121.3 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
17.2 | 68.7 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
17.1 | 51.3 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
17.1 | 51.3 | GO:0005119 | smoothened binding(GO:0005119) |
16.9 | 101.7 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
16.9 | 84.7 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
16.9 | 50.8 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
16.9 | 84.3 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
16.6 | 33.2 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
16.6 | 66.4 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
16.6 | 66.3 | GO:0038132 | neuregulin binding(GO:0038132) |
16.5 | 82.4 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
16.5 | 82.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
16.4 | 49.3 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
16.4 | 49.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
16.4 | 687.3 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
16.4 | 98.2 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
16.3 | 48.8 | GO:0004103 | choline kinase activity(GO:0004103) |
16.2 | 65.0 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
16.1 | 64.5 | GO:0008430 | selenium binding(GO:0008430) |
16.1 | 16.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
16.1 | 64.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
16.1 | 48.3 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
16.1 | 32.2 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
16.0 | 32.1 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
16.0 | 80.0 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
16.0 | 32.0 | GO:0004104 | cholinesterase activity(GO:0004104) |
16.0 | 80.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
16.0 | 143.8 | GO:0032452 | histone demethylase activity(GO:0032452) |
15.9 | 127.5 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
15.9 | 63.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
15.9 | 15.9 | GO:0003696 | satellite DNA binding(GO:0003696) |
15.9 | 47.6 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
15.8 | 15.8 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
15.8 | 346.5 | GO:0001221 | transcription cofactor binding(GO:0001221) |
15.7 | 47.1 | GO:0019770 | IgG receptor activity(GO:0019770) |
15.7 | 125.3 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
15.6 | 46.9 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
15.6 | 46.8 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
15.5 | 46.5 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
15.5 | 46.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
15.4 | 46.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
15.3 | 122.4 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
15.2 | 121.3 | GO:0019789 | SUMO transferase activity(GO:0019789) |
15.1 | 15.1 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
15.1 | 15.1 | GO:0045503 | dynein light chain binding(GO:0045503) |
15.1 | 211.7 | GO:0050681 | androgen receptor binding(GO:0050681) |
15.0 | 45.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
15.0 | 44.9 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
14.9 | 74.7 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
14.9 | 432.2 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
14.9 | 193.2 | GO:0005521 | lamin binding(GO:0005521) |
14.8 | 74.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
14.8 | 44.5 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
14.8 | 326.0 | GO:0005158 | insulin receptor binding(GO:0005158) |
14.8 | 88.7 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
14.8 | 206.9 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
14.8 | 73.8 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
14.7 | 59.0 | GO:0043515 | kinetochore binding(GO:0043515) |
14.7 | 132.4 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
14.7 | 73.5 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
14.7 | 44.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
14.6 | 175.7 | GO:0005123 | death receptor binding(GO:0005123) |
14.6 | 58.4 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) |
14.5 | 551.9 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
14.5 | 101.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
14.5 | 115.7 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
14.4 | 28.9 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
14.4 | 172.7 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
14.3 | 71.7 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
14.3 | 71.7 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
14.3 | 128.6 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
14.3 | 57.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
14.2 | 42.7 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
14.2 | 28.5 | GO:0016748 | succinyltransferase activity(GO:0016748) |
14.2 | 14.2 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) peptide transmembrane transporter activity(GO:1904680) |
14.2 | 56.7 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
14.2 | 56.7 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
14.1 | 42.4 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
14.1 | 56.2 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
14.0 | 28.1 | GO:0030172 | troponin C binding(GO:0030172) |
14.0 | 56.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
14.0 | 14.0 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
14.0 | 56.0 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
14.0 | 112.0 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
13.9 | 223.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
13.9 | 138.9 | GO:0035497 | cAMP response element binding(GO:0035497) |
13.9 | 125.0 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
13.9 | 55.5 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
13.8 | 276.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
13.8 | 855.0 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
13.8 | 179.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
13.7 | 95.9 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
13.7 | 150.7 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
13.7 | 82.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
13.7 | 68.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
13.7 | 54.7 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
13.6 | 40.8 | GO:0043559 | insulin binding(GO:0043559) |
13.6 | 54.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
13.6 | 40.8 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
13.6 | 13.6 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
13.5 | 81.3 | GO:0030983 | mismatched DNA binding(GO:0030983) |
13.5 | 40.6 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
13.5 | 40.6 | GO:0030515 | snoRNA binding(GO:0030515) |
13.5 | 54.0 | GO:0015057 | thrombin receptor activity(GO:0015057) |
13.5 | 53.9 | GO:0015232 | heme transporter activity(GO:0015232) |
13.5 | 40.4 | GO:0031014 | troponin T binding(GO:0031014) |
13.5 | 26.9 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
13.4 | 40.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
13.3 | 186.8 | GO:0001618 | virus receptor activity(GO:0001618) |
13.3 | 160.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
13.3 | 53.3 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
13.3 | 13.3 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
13.3 | 26.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
13.3 | 199.0 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
13.3 | 53.0 | GO:0034618 | arginine binding(GO:0034618) |
13.2 | 79.2 | GO:0000182 | rDNA binding(GO:0000182) |
13.1 | 78.8 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
13.1 | 65.4 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
13.1 | 26.1 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
13.1 | 13.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
13.1 | 65.3 | GO:0015288 | porin activity(GO:0015288) |
13.1 | 39.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
12.9 | 38.8 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
12.9 | 25.9 | GO:0070568 | RNA guanylyltransferase activity(GO:0008192) guanylyltransferase activity(GO:0070568) |
12.9 | 25.8 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
12.9 | 321.5 | GO:0042162 | telomeric DNA binding(GO:0042162) |
12.8 | 12.8 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
12.8 | 12.8 | GO:0042609 | CD4 receptor binding(GO:0042609) |
12.8 | 128.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
12.8 | 76.9 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
12.8 | 230.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
12.7 | 12.7 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
12.6 | 50.6 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
12.6 | 63.1 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
12.6 | 150.7 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
12.5 | 37.5 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
12.5 | 162.5 | GO:0034573 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
12.5 | 1111.3 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
12.5 | 87.3 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
12.4 | 87.0 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
12.4 | 74.4 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
12.4 | 37.1 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
12.4 | 37.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
12.4 | 37.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
12.3 | 221.9 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
12.3 | 209.4 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
12.3 | 12.3 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
12.3 | 356.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
12.2 | 134.7 | GO:0032183 | SUMO binding(GO:0032183) |
12.2 | 232.4 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
12.2 | 256.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
12.2 | 366.8 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
12.2 | 158.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
12.2 | 12.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
12.2 | 24.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
12.2 | 24.3 | GO:0043842 | Kdo transferase activity(GO:0043842) |
12.2 | 12.2 | GO:0048156 | tau protein binding(GO:0048156) |
12.1 | 109.3 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
12.1 | 24.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
12.1 | 750.3 | GO:0035326 | enhancer binding(GO:0035326) |
12.1 | 60.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
12.0 | 36.1 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
12.0 | 84.1 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
12.0 | 12.0 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
12.0 | 36.0 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
12.0 | 12.0 | GO:0035173 | histone kinase activity(GO:0035173) |
12.0 | 35.9 | GO:0016530 | metallochaperone activity(GO:0016530) |
11.9 | 23.9 | GO:0051379 | alpha2-adrenergic receptor activity(GO:0004938) epinephrine binding(GO:0051379) |
11.9 | 178.4 | GO:0045502 | dynein binding(GO:0045502) |
11.9 | 1150.8 | GO:0017137 | Rab GTPase binding(GO:0017137) |
11.9 | 35.6 | GO:0004064 | arylesterase activity(GO:0004064) |
11.8 | 106.5 | GO:0031996 | thioesterase binding(GO:0031996) |
11.8 | 94.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
11.8 | 141.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
11.8 | 35.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
11.7 | 46.7 | GO:0070513 | death domain binding(GO:0070513) |
11.6 | 174.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
11.6 | 58.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
11.6 | 69.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
11.6 | 23.2 | GO:0030619 | U1 snRNA binding(GO:0030619) |
11.6 | 590.3 | GO:0017048 | Rho GTPase binding(GO:0017048) |
11.6 | 81.0 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
11.5 | 23.1 | GO:0030984 | kininogen binding(GO:0030984) |
11.5 | 115.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
11.5 | 11.5 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
11.5 | 218.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
11.5 | 206.3 | GO:0030507 | spectrin binding(GO:0030507) |
11.4 | 785.9 | GO:0001047 | core promoter binding(GO:0001047) |
11.4 | 34.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
11.4 | 45.4 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
11.4 | 272.5 | GO:0070063 | RNA polymerase binding(GO:0070063) |
11.4 | 22.7 | GO:0042379 | chemokine receptor binding(GO:0042379) |
11.3 | 34.0 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
11.3 | 45.4 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
11.3 | 11.3 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
11.2 | 89.7 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
11.2 | 78.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
11.2 | 33.5 | GO:0019002 | GMP binding(GO:0019002) |
11.1 | 688.8 | GO:0031072 | heat shock protein binding(GO:0031072) |
11.1 | 77.4 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
11.0 | 44.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
11.0 | 22.0 | GO:0031685 | adenosine receptor binding(GO:0031685) |
11.0 | 22.0 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
11.0 | 33.0 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
11.0 | 87.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
11.0 | 11.0 | GO:0070538 | oleic acid binding(GO:0070538) |
10.9 | 21.8 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
10.8 | 10.8 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
10.8 | 313.5 | GO:0035064 | methylated histone binding(GO:0035064) |
10.8 | 10.8 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
10.7 | 53.5 | GO:0070728 | leucine binding(GO:0070728) |
10.6 | 42.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
10.6 | 53.2 | GO:0005522 | profilin binding(GO:0005522) |
10.6 | 222.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
10.6 | 21.2 | GO:0015928 | fucosidase activity(GO:0015928) |
10.5 | 31.6 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
10.5 | 84.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
10.5 | 84.0 | GO:0070097 | delta-catenin binding(GO:0070097) |
10.5 | 21.0 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
10.5 | 10.5 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) rRNA (uridine) methyltransferase activity(GO:0016436) |
10.5 | 83.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
10.4 | 31.3 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
10.4 | 31.2 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
10.4 | 362.3 | GO:0042826 | histone deacetylase binding(GO:0042826) |
10.3 | 196.6 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
10.3 | 866.8 | GO:0003714 | transcription corepressor activity(GO:0003714) |
10.3 | 154.5 | GO:0043130 | ubiquitin binding(GO:0043130) |
10.3 | 10.3 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
10.3 | 61.6 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
10.3 | 1374.0 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
10.2 | 61.4 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
10.2 | 51.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
10.2 | 184.0 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
10.2 | 71.4 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
10.2 | 132.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
10.2 | 10.2 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
10.1 | 30.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
10.1 | 70.7 | GO:0003684 | damaged DNA binding(GO:0003684) |
10.1 | 181.2 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
10.1 | 100.5 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
10.0 | 40.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
10.0 | 30.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
10.0 | 20.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
10.0 | 10.0 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
10.0 | 796.8 | GO:0051015 | actin filament binding(GO:0051015) |
9.9 | 69.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
9.9 | 534.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
9.9 | 79.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
9.9 | 39.6 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
9.9 | 29.7 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
9.9 | 49.4 | GO:0005536 | glucose binding(GO:0005536) |
9.8 | 9.8 | GO:0005047 | signal recognition particle binding(GO:0005047) |
9.8 | 19.5 | GO:0030274 | LIM domain binding(GO:0030274) |
9.8 | 29.3 | GO:1990405 | protein antigen binding(GO:1990405) |
9.8 | 117.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
9.7 | 19.5 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
9.7 | 9.7 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
9.7 | 875.1 | GO:0008766 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
9.7 | 9.7 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
9.7 | 67.8 | GO:0019957 | C-C chemokine binding(GO:0019957) |
9.7 | 9.7 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
9.7 | 58.0 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
9.7 | 19.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
9.7 | 19.3 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
9.6 | 202.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
9.6 | 86.3 | GO:0034522 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
9.6 | 28.7 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
9.5 | 66.7 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
9.5 | 19.0 | GO:0051425 | PTB domain binding(GO:0051425) |
9.5 | 18.9 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
9.5 | 246.3 | GO:0015485 | cholesterol binding(GO:0015485) |
9.5 | 56.7 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
9.5 | 37.8 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
9.4 | 56.7 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
9.4 | 37.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
9.4 | 47.0 | GO:0016936 | galactoside binding(GO:0016936) |
9.4 | 18.8 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
9.3 | 46.6 | GO:0018654 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
9.3 | 83.9 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
9.3 | 158.3 | GO:0001848 | complement binding(GO:0001848) |
9.3 | 92.8 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
9.2 | 37.0 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
9.2 | 18.4 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
9.1 | 164.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
9.1 | 355.2 | GO:0042393 | histone binding(GO:0042393) |
9.1 | 18.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
9.1 | 45.5 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
9.1 | 18.2 | GO:0000405 | bubble DNA binding(GO:0000405) |
9.1 | 27.3 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
9.1 | 36.4 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
9.1 | 81.5 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
9.0 | 560.4 | GO:0003713 | transcription coactivator activity(GO:0003713) |
9.0 | 27.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
9.0 | 180.6 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
9.0 | 45.0 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
8.9 | 80.4 | GO:0034843 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
8.9 | 26.8 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
8.9 | 17.8 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
8.9 | 80.3 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
8.9 | 17.8 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
8.9 | 204.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
8.9 | 44.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
8.9 | 26.7 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
8.8 | 79.6 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
8.8 | 44.1 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
8.8 | 281.4 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
8.8 | 26.4 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
8.8 | 123.0 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
8.8 | 43.8 | GO:0008097 | 5S rRNA binding(GO:0008097) |
8.8 | 17.5 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
8.8 | 332.7 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
8.7 | 26.2 | GO:0043199 | sulfate binding(GO:0043199) |
8.7 | 26.2 | GO:0005534 | galactose binding(GO:0005534) |
8.7 | 17.5 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
8.6 | 95.1 | GO:0010181 | FMN binding(GO:0010181) |
8.6 | 17.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
8.6 | 43.0 | GO:1990446 | U1 snRNP binding(GO:1990446) |
8.6 | 34.4 | GO:0005113 | patched binding(GO:0005113) |
8.6 | 34.3 | GO:0070403 | NAD+ binding(GO:0070403) |
8.5 | 34.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
8.5 | 536.9 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
8.5 | 68.1 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
8.5 | 93.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
8.5 | 50.9 | GO:0042301 | phosphate ion binding(GO:0042301) |
8.5 | 8.5 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
8.5 | 33.9 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
8.4 | 244.8 | GO:0005484 | SNAP receptor activity(GO:0005484) |
8.4 | 16.7 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
8.4 | 8.4 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
8.4 | 50.2 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
8.3 | 16.7 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
8.3 | 33.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
8.3 | 24.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
8.3 | 174.1 | GO:0043236 | laminin binding(GO:0043236) |
8.3 | 1183.9 | GO:0008134 | transcription factor binding(GO:0008134) |
8.2 | 16.4 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
8.2 | 90.3 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
8.2 | 90.1 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
8.1 | 358.0 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
8.1 | 40.6 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
8.1 | 16.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
8.1 | 40.3 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
8.0 | 72.4 | GO:0060590 | ATPase regulator activity(GO:0060590) |
8.0 | 48.3 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
8.0 | 64.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
8.0 | 72.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
8.0 | 88.0 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
8.0 | 95.9 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
8.0 | 103.6 | GO:0008198 | ferrous iron binding(GO:0008198) |
8.0 | 23.9 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
7.9 | 23.8 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
7.9 | 7.9 | GO:0004096 | catalase activity(GO:0004096) |
7.9 | 15.8 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
7.9 | 78.7 | GO:0045296 | cadherin binding(GO:0045296) |
7.9 | 39.3 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
7.8 | 15.7 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
7.8 | 39.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
7.8 | 31.3 | GO:0035197 | siRNA binding(GO:0035197) |
7.8 | 187.6 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
7.8 | 23.4 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
7.8 | 85.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
7.7 | 294.0 | GO:0051020 | GTPase binding(GO:0051020) |
7.7 | 30.9 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
7.7 | 54.0 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
7.7 | 23.1 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
7.7 | 53.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
7.7 | 76.9 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
7.7 | 23.0 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
7.7 | 7.7 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
7.6 | 68.7 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
7.6 | 15.3 | GO:0031369 | translation initiation factor binding(GO:0031369) |
7.6 | 83.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
7.6 | 1309.3 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
7.6 | 7.6 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
7.6 | 53.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
7.6 | 53.1 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
7.5 | 37.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
7.5 | 7.5 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
7.5 | 262.8 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
7.5 | 15.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
7.5 | 44.9 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
7.5 | 22.4 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
7.4 | 44.6 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
7.4 | 141.1 | GO:0008483 | transaminase activity(GO:0008483) |
7.4 | 215.2 | GO:0030674 | protein binding, bridging(GO:0030674) |
7.4 | 22.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
7.4 | 154.4 | GO:0008748 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
7.3 | 14.7 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
7.3 | 22.0 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
7.3 | 14.6 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
7.3 | 87.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
7.3 | 36.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
7.3 | 21.8 | GO:0070492 | oligosaccharide binding(GO:0070492) |
7.3 | 138.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
7.2 | 137.7 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
7.2 | 43.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
7.2 | 64.7 | GO:0016504 | peptidase activator activity(GO:0016504) |
7.2 | 43.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
7.2 | 35.9 | GO:0002039 | p53 binding(GO:0002039) |
7.2 | 100.4 | GO:0003712 | transcription cofactor activity(GO:0003712) |
7.2 | 14.3 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
7.1 | 78.6 | GO:0048038 | quinone binding(GO:0048038) |
7.1 | 142.8 | GO:0048487 | beta-tubulin binding(GO:0048487) |
7.1 | 142.6 | GO:0043621 | protein self-association(GO:0043621) |
7.1 | 56.9 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
7.1 | 21.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
7.1 | 35.5 | GO:0043422 | protein kinase B binding(GO:0043422) |
7.0 | 295.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
7.0 | 21.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
7.0 | 490.4 | GO:0017124 | SH3 domain binding(GO:0017124) |
7.0 | 27.8 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
7.0 | 132.3 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
6.9 | 69.1 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
6.9 | 27.5 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
6.9 | 20.6 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
6.8 | 13.7 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
6.8 | 20.3 | GO:0019808 | polyamine binding(GO:0019808) |
6.8 | 155.5 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
6.8 | 108.1 | GO:0004177 | aminopeptidase activity(GO:0004177) |
6.7 | 13.5 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
6.7 | 20.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
6.7 | 107.8 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
6.7 | 6.7 | GO:0050815 | phosphoserine binding(GO:0050815) |
6.7 | 20.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
6.7 | 20.1 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
6.7 | 6.7 | GO:0030492 | hemoglobin binding(GO:0030492) |
6.7 | 13.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
6.7 | 13.4 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
6.7 | 399.6 | GO:0005178 | integrin binding(GO:0005178) |
6.7 | 20.0 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
6.6 | 86.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
6.6 | 13.3 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
6.6 | 46.2 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
6.6 | 151.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
6.6 | 19.7 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
6.5 | 6.5 | GO:0070698 | type I activin receptor binding(GO:0070698) |
6.5 | 45.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
6.5 | 45.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
6.4 | 64.4 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
6.4 | 32.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
6.4 | 38.4 | GO:0034185 | apolipoprotein binding(GO:0034185) |
6.4 | 6.4 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
6.4 | 76.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
6.4 | 25.4 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
6.3 | 38.1 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
6.3 | 113.7 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
6.3 | 592.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
6.3 | 6.3 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
6.3 | 6.3 | GO:0030371 | translation repressor activity(GO:0030371) |
6.3 | 144.0 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
6.2 | 18.7 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
6.2 | 24.9 | GO:0031419 | cobalamin binding(GO:0031419) |
6.2 | 62.3 | GO:0031489 | myosin V binding(GO:0031489) |
6.2 | 6.2 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
6.2 | 12.4 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
6.2 | 12.4 | GO:0019215 | intermediate filament binding(GO:0019215) |
6.2 | 6.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
6.2 | 24.7 | GO:0016208 | AMP binding(GO:0016208) |
6.2 | 61.6 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
6.2 | 18.5 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
6.2 | 30.8 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
6.2 | 18.5 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
6.2 | 129.2 | GO:0050699 | WW domain binding(GO:0050699) |
6.1 | 18.4 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
6.1 | 12.3 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
6.1 | 12.3 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
6.1 | 18.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
6.1 | 24.5 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
6.1 | 360.0 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
6.1 | 200.2 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
6.1 | 6.1 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
6.0 | 6.0 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
6.0 | 18.0 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
6.0 | 29.9 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
6.0 | 17.9 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
6.0 | 59.7 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
6.0 | 113.4 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
6.0 | 47.7 | GO:0038191 | neuropilin binding(GO:0038191) |
5.9 | 17.8 | GO:0016015 | morphogen activity(GO:0016015) |
5.9 | 76.7 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
5.9 | 29.4 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
5.9 | 3785.6 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
5.8 | 40.9 | GO:0039706 | co-receptor binding(GO:0039706) |
5.8 | 11.7 | GO:0034452 | dynactin binding(GO:0034452) |
5.8 | 157.1 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
5.8 | 209.4 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
5.8 | 11.6 | GO:0015925 | galactosidase activity(GO:0015925) |
5.8 | 11.5 | GO:0019213 | deacetylase activity(GO:0019213) |
5.8 | 34.6 | GO:0034793 | acyl-CoA ligase activity(GO:0003996) succinate-CoA ligase activity(GO:0004774) 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
5.7 | 5.7 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
5.7 | 5.7 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
5.7 | 5.7 | GO:0018589 | fluorene oxygenase activity(GO:0018585) mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
5.6 | 11.3 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
5.6 | 27.8 | GO:0005499 | vitamin D binding(GO:0005499) |
5.6 | 5.6 | GO:0046790 | virion binding(GO:0046790) |
5.5 | 16.6 | GO:0060090 | binding, bridging(GO:0060090) |
5.5 | 11.0 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
5.5 | 10.9 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
5.4 | 5.4 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
5.4 | 48.8 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
5.4 | 59.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
5.4 | 156.2 | GO:0008168 | methyltransferase activity(GO:0008168) |
5.4 | 42.9 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
5.4 | 26.8 | GO:0070628 | proteasome binding(GO:0070628) |
5.3 | 10.6 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
5.3 | 63.7 | GO:0017022 | myosin binding(GO:0017022) |
5.3 | 5.3 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
5.3 | 21.1 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
5.3 | 73.8 | GO:0051087 | chaperone binding(GO:0051087) |
5.3 | 26.3 | GO:0050700 | CARD domain binding(GO:0050700) |
5.3 | 21.0 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
5.2 | 20.9 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
5.2 | 15.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
5.2 | 10.4 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
5.2 | 67.5 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
5.2 | 5.2 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
5.2 | 362.5 | GO:0003774 | motor activity(GO:0003774) |
5.2 | 5.2 | GO:0004386 | helicase activity(GO:0004386) |
5.2 | 15.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
5.2 | 217.3 | GO:0008565 | protein transporter activity(GO:0008565) |
5.2 | 10.3 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
5.1 | 35.9 | GO:0016836 | hydro-lyase activity(GO:0016836) |
5.1 | 553.4 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
5.1 | 10.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
5.1 | 15.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
5.1 | 15.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
5.0 | 15.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
5.0 | 1094.4 | GO:0005525 | GTP binding(GO:0005525) |
5.0 | 115.7 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
5.0 | 5.0 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
5.0 | 10.1 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
5.0 | 75.2 | GO:0031593 | polyubiquitin binding(GO:0031593) |
5.0 | 14.9 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
4.9 | 4077.9 | GO:0003677 | DNA binding(GO:0003677) |
4.9 | 34.6 | GO:0004622 | lysophospholipase activity(GO:0004622) |
4.9 | 44.4 | GO:0000049 | tRNA binding(GO:0000049) |
4.9 | 24.5 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
4.9 | 4.9 | GO:0038181 | bile acid receptor activity(GO:0038181) |
4.9 | 82.9 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
4.8 | 9.7 | GO:0070034 | telomerase RNA binding(GO:0070034) |
4.8 | 159.5 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
4.8 | 48.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
4.8 | 58.0 | GO:0019239 | deaminase activity(GO:0019239) |
4.8 | 28.8 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
4.8 | 9.6 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
4.8 | 14.3 | GO:0038100 | nodal binding(GO:0038100) |
4.7 | 455.1 | GO:0005096 | GTPase activator activity(GO:0005096) |
4.7 | 19.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
4.7 | 28.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
4.7 | 33.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
4.7 | 18.8 | GO:0004966 | galanin receptor activity(GO:0004966) |
4.6 | 18.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
4.6 | 13.9 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
4.6 | 13.9 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
4.6 | 27.7 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
4.6 | 13.8 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
4.6 | 55.3 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
4.5 | 13.6 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
4.5 | 36.1 | GO:0004568 | chitinase activity(GO:0004568) |
4.5 | 31.4 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
4.5 | 31.3 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
4.5 | 8.9 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
4.4 | 8.9 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
4.4 | 22.1 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
4.4 | 8.8 | GO:0071253 | connexin binding(GO:0071253) |
4.4 | 21.9 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
4.4 | 4.4 | GO:0019862 | IgA binding(GO:0019862) |
4.4 | 13.1 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
4.3 | 34.7 | GO:0043022 | ribosome binding(GO:0043022) |
4.3 | 528.5 | GO:0003779 | actin binding(GO:0003779) |
4.3 | 8.6 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
4.3 | 8.6 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
4.3 | 21.4 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
4.3 | 4.3 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
4.3 | 85.1 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
4.3 | 25.5 | GO:0016878 | acid-thiol ligase activity(GO:0016878) |
4.2 | 114.6 | GO:0005507 | copper ion binding(GO:0005507) |
4.2 | 21.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
4.2 | 105.7 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
4.2 | 79.9 | GO:0008013 | beta-catenin binding(GO:0008013) |
4.2 | 16.8 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
4.2 | 12.5 | GO:0070182 | DNA polymerase binding(GO:0070182) |
4.2 | 50.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
4.2 | 33.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
4.2 | 41.6 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
4.2 | 8.3 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
4.1 | 12.4 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
4.1 | 20.5 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
4.1 | 16.3 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
4.1 | 12.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
4.0 | 1055.2 | GO:0008270 | zinc ion binding(GO:0008270) |
4.0 | 20.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
4.0 | 24.0 | GO:0071813 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
4.0 | 8.0 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
4.0 | 47.8 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
4.0 | 43.8 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
4.0 | 11.9 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
4.0 | 7.9 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
4.0 | 11.9 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
4.0 | 4.0 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
3.9 | 7.8 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
3.9 | 3.9 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
3.9 | 3.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
3.9 | 11.6 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
3.8 | 111.5 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
3.8 | 7.7 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
3.8 | 3.8 | GO:0016972 | thiol oxidase activity(GO:0016972) |
3.8 | 186.2 | GO:0016853 | isomerase activity(GO:0016853) |
3.8 | 15.1 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
3.7 | 44.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
3.7 | 14.9 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
3.7 | 29.7 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
3.7 | 14.8 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
3.7 | 169.6 | GO:0004857 | enzyme inhibitor activity(GO:0004857) |
3.7 | 51.6 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
3.7 | 25.6 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
3.6 | 32.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
3.6 | 21.8 | GO:0070700 | BMP receptor binding(GO:0070700) |
3.6 | 154.3 | GO:0019902 | phosphatase binding(GO:0019902) |
3.6 | 35.9 | GO:0043734 | DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
3.6 | 21.5 | GO:0019966 | interleukin-1 binding(GO:0019966) |
3.5 | 10.6 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
3.5 | 6.9 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
3.4 | 10.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
3.4 | 6.9 | GO:0035473 | lipase binding(GO:0035473) |
3.4 | 3.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
3.4 | 84.8 | GO:0051723 | protein methylesterase activity(GO:0051723) |
3.4 | 125.2 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
3.4 | 10.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
3.4 | 6.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
3.3 | 26.6 | GO:0042805 | actinin binding(GO:0042805) |
3.3 | 108.5 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
3.3 | 23.0 | GO:0005506 | iron ion binding(GO:0005506) |
3.3 | 3.3 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
3.3 | 101.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
3.2 | 9.7 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
3.2 | 6.5 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
3.2 | 6.5 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
3.2 | 649.1 | GO:0004175 | endopeptidase activity(GO:0004175) |
3.2 | 48.3 | GO:0051117 | ATPase binding(GO:0051117) |
3.2 | 9.6 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
3.2 | 3.2 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
3.2 | 53.9 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
3.2 | 31.6 | GO:0004521 | endoribonuclease activity(GO:0004521) |
3.1 | 77.9 | GO:0005496 | steroid binding(GO:0005496) |
3.1 | 6.2 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
3.1 | 3.1 | GO:0019956 | chemokine binding(GO:0019956) |
3.1 | 6.1 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
3.0 | 661.2 | GO:0005198 | structural molecule activity(GO:0005198) |
3.0 | 36.4 | GO:0022842 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
3.0 | 63.4 | GO:0004518 | nuclease activity(GO:0004518) |
3.0 | 3.0 | GO:0051373 | FATZ binding(GO:0051373) |
3.0 | 23.8 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
3.0 | 14.9 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
3.0 | 8.9 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
2.9 | 29.3 | GO:0015926 | glucosidase activity(GO:0015926) |
2.9 | 58.0 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
2.9 | 2.9 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
2.8 | 8.5 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
2.8 | 42.6 | GO:0005537 | mannose binding(GO:0005537) |
2.8 | 5.7 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
2.8 | 2.8 | GO:0019207 | kinase regulator activity(GO:0019207) |
2.8 | 8.4 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
2.8 | 8.4 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
2.8 | 11.2 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
2.8 | 2.8 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
2.8 | 11.1 | GO:0015643 | toxic substance binding(GO:0015643) |
2.8 | 143.8 | GO:0044389 | ubiquitin-like protein ligase binding(GO:0044389) |
2.8 | 278.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
2.8 | 22.1 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
2.7 | 13.7 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
2.7 | 2.7 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
2.7 | 5.5 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
2.7 | 2.7 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
2.7 | 379.8 | GO:0003676 | nucleic acid binding(GO:0003676) |
2.7 | 5.4 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
2.7 | 10.6 | GO:0032451 | demethylase activity(GO:0032451) |
2.6 | 78.6 | GO:0000149 | SNARE binding(GO:0000149) |
2.6 | 41.5 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
2.6 | 25.9 | GO:0005243 | gap junction channel activity(GO:0005243) |
2.6 | 7.8 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
2.6 | 7.7 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
2.6 | 15.4 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
2.5 | 91.0 | GO:0015405 | primary active transmembrane transporter activity(GO:0015399) P-P-bond-hydrolysis-driven transmembrane transporter activity(GO:0015405) |
2.5 | 17.6 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
2.5 | 2.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
2.5 | 15.0 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
2.5 | 2.5 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
2.5 | 39.6 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
2.5 | 170.2 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
2.5 | 2.5 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
2.4 | 317.2 | GO:0005125 | cytokine activity(GO:0005125) |
2.4 | 2.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
2.4 | 16.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
2.4 | 54.5 | GO:0016887 | ATPase activity(GO:0016887) |
2.3 | 6.9 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
2.3 | 13.8 | GO:0005048 | signal sequence binding(GO:0005048) |
2.3 | 25.1 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
2.2 | 339.8 | GO:0019899 | enzyme binding(GO:0019899) |
2.2 | 6.6 | GO:0019864 | IgG binding(GO:0019864) |
2.2 | 8.6 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
2.1 | 8.6 | GO:0004459 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
2.1 | 4.2 | GO:0008199 | ferric iron binding(GO:0008199) |
2.1 | 2.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
2.0 | 2.0 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
2.0 | 12.2 | GO:0000287 | magnesium ion binding(GO:0000287) |
2.0 | 8.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
2.0 | 25.7 | GO:0005044 | scavenger receptor activity(GO:0005044) |
2.0 | 3.9 | GO:0043531 | ADP binding(GO:0043531) |
2.0 | 11.7 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
1.9 | 1.9 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
1.9 | 1.9 | GO:0015665 | alcohol transmembrane transporter activity(GO:0015665) |
1.9 | 1.9 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
1.9 | 5.7 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
1.9 | 5.7 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
1.9 | 5.7 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
1.8 | 3.6 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
1.8 | 7.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
1.8 | 7.2 | GO:0030145 | manganese ion binding(GO:0030145) |
1.8 | 7.2 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
1.8 | 9.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
1.8 | 17.7 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
1.8 | 3.5 | GO:0051870 | methotrexate binding(GO:0051870) |
1.7 | 1.7 | GO:0015927 | trehalase activity(GO:0015927) |
1.7 | 1.7 | GO:0001846 | opsonin binding(GO:0001846) |
1.7 | 5.1 | GO:0019865 | immunoglobulin binding(GO:0019865) |
1.7 | 5.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
1.7 | 16.7 | GO:0051287 | NAD binding(GO:0051287) |
1.6 | 11.4 | GO:0003796 | lysozyme activity(GO:0003796) |
1.6 | 29.3 | GO:0005319 | lipid transporter activity(GO:0005319) |
1.6 | 3.2 | GO:0016595 | glutamate binding(GO:0016595) |
1.6 | 4.8 | GO:0019976 | interleukin-2 binding(GO:0019976) |
1.5 | 38.7 | GO:0008022 | protein C-terminus binding(GO:0008022) |
1.5 | 1.5 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
1.5 | 3.0 | GO:0070402 | NADPH binding(GO:0070402) |
1.5 | 1.5 | GO:0004645 | phosphorylase activity(GO:0004645) |
1.5 | 1.5 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
1.5 | 2.9 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
1.4 | 26.7 | GO:0042605 | peptide antigen binding(GO:0042605) |
1.4 | 1.4 | GO:0031404 | chloride ion binding(GO:0031404) |
1.3 | 51.3 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
1.3 | 3.9 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.2 | 2.5 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
1.2 | 9.8 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
1.2 | 1.2 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
1.1 | 4.5 | GO:0030695 | GTPase regulator activity(GO:0030695) |
1.1 | 3.4 | GO:0050780 | dopamine receptor binding(GO:0050780) |
1.1 | 3.4 | GO:0008410 | CoA-transferase activity(GO:0008410) |
1.1 | 1.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
1.1 | 5.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
1.1 | 1.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
1.1 | 9.9 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
1.0 | 38.5 | GO:0008527 | taste receptor activity(GO:0008527) |
1.0 | 3.8 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.9 | 82.9 | GO:0019904 | protein domain specific binding(GO:0019904) |
0.9 | 1.8 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.9 | 97.1 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.9 | 10.6 | GO:0003823 | antigen binding(GO:0003823) |
0.9 | 9.6 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.8 | 1.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.8 | 0.8 | GO:0070052 | collagen V binding(GO:0070052) |
0.8 | 1.5 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.7 | 7.5 | GO:0005112 | Notch binding(GO:0005112) |
0.7 | 3.5 | GO:0031386 | protein tag(GO:0031386) |
0.7 | 61.5 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.6 | 0.6 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.6 | 1.8 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.6 | 1.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.5 | 42.4 | GO:0005179 | hormone activity(GO:0005179) |
0.5 | 2.5 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.5 | 2.0 | GO:0009055 | electron carrier activity(GO:0009055) |
0.5 | 0.5 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.5 | 0.5 | GO:2001069 | glycogen binding(GO:2001069) |
0.5 | 1.4 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.5 | 3.7 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.5 | 2.8 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.5 | 0.9 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.5 | 0.5 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.4 | 0.4 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.4 | 1.2 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.4 | 0.8 | GO:0046332 | SMAD binding(GO:0046332) |
0.4 | 0.7 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.4 | 1.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.4 | 1.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.3 | 66.9 | GO:0042802 | identical protein binding(GO:0042802) |
0.3 | 0.3 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
0.3 | 2.5 | GO:0005550 | pheromone binding(GO:0005550) |
0.3 | 0.6 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.3 | 1.2 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.3 | 5.2 | GO:0020037 | heme binding(GO:0020037) |
0.3 | 0.3 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.3 | 5.9 | GO:0016791 | phosphatase activity(GO:0016791) |
0.3 | 36.0 | GO:0008289 | lipid binding(GO:0008289) |
0.3 | 1.8 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 0.5 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.2 | 0.7 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 22.5 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.2 | 3.2 | GO:0005186 | pheromone activity(GO:0005186) |
0.2 | 2.8 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.2 | 1.1 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.2 | 4.1 | GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors(GO:0016614) |
0.2 | 0.2 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 130.7 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.1 | 0.3 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.1 | 0.1 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.1 | 0.1 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.0 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
30.0 | 300.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
29.9 | 776.1 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
29.5 | 826.6 | PID IGF1 PATHWAY | IGF1 pathway |
25.9 | 181.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
25.5 | 357.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
25.3 | 530.3 | PID EPO PATHWAY | EPO signaling pathway |
25.1 | 150.7 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
24.5 | 171.5 | ST STAT3 PATHWAY | STAT3 Pathway |
24.2 | 48.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
23.1 | 393.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
23.1 | 508.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
22.9 | 298.0 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
22.6 | 789.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
22.3 | 424.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
22.1 | 1036.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
21.9 | 306.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
21.8 | 1135.5 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
21.8 | 304.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
21.6 | 259.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
21.5 | 258.5 | PID IFNG PATHWAY | IFN-gamma pathway |
20.4 | 183.7 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
20.2 | 100.8 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
20.0 | 638.7 | PID RHOA PATHWAY | RhoA signaling pathway |
20.0 | 199.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
19.5 | 604.0 | PID ARF6 PATHWAY | Arf6 signaling events |
19.5 | 19.5 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
18.4 | 257.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
17.8 | 35.7 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
17.5 | 630.4 | PID P53 REGULATION PATHWAY | p53 pathway |
17.5 | 209.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
16.5 | 281.3 | PID MYC PATHWAY | C-MYC pathway |
16.5 | 181.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
16.4 | 131.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
16.0 | 528.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
15.8 | 47.4 | PID ALK2 PATHWAY | ALK2 signaling events |
15.3 | 106.8 | PID S1P S1P1 PATHWAY | S1P1 pathway |
15.2 | 334.8 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
15.1 | 393.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
15.0 | 630.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
15.0 | 45.0 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
14.8 | 251.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
14.5 | 72.7 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
14.5 | 144.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
14.1 | 98.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
13.9 | 598.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
13.9 | 166.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
13.8 | 345.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
13.5 | 418.7 | PID PLK1 PATHWAY | PLK1 signaling events |
13.5 | 94.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
13.3 | 239.6 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
13.3 | 26.6 | ST GA12 PATHWAY | G alpha 12 Pathway |
13.3 | 26.5 | PID S1P S1P2 PATHWAY | S1P2 pathway |
13.1 | 13.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
13.0 | 156.5 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
12.9 | 257.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
12.6 | 403.8 | PID AP1 PATHWAY | AP-1 transcription factor network |
12.5 | 99.7 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
12.3 | 355.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
12.1 | 412.2 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
11.8 | 188.3 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
11.7 | 222.9 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
11.7 | 151.9 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
11.7 | 23.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
11.6 | 23.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
11.5 | 424.5 | PID P73PATHWAY | p73 transcription factor network |
11.4 | 308.8 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
11.4 | 34.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
11.2 | 213.6 | PID RAS PATHWAY | Regulation of Ras family activation |
11.0 | 142.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
10.8 | 75.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
10.8 | 322.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
10.6 | 74.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
10.6 | 63.5 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
10.5 | 210.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
10.5 | 272.6 | PID E2F PATHWAY | E2F transcription factor network |
10.4 | 229.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
10.4 | 114.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
10.3 | 41.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
10.2 | 172.8 | PID ALK1 PATHWAY | ALK1 signaling events |
9.9 | 118.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
9.9 | 157.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
9.8 | 167.3 | PID LKB1 PATHWAY | LKB1 signaling events |
9.8 | 107.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
9.5 | 124.0 | PID BARD1 PATHWAY | BARD1 signaling events |
9.5 | 9.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
9.5 | 199.6 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
9.5 | 180.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
9.5 | 227.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
9.3 | 130.0 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
9.3 | 37.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
9.2 | 82.7 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
9.1 | 91.5 | PID ARF 3PATHWAY | Arf1 pathway |
9.0 | 152.3 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
8.9 | 293.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
8.9 | 79.9 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
8.9 | 115.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
8.8 | 441.0 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
8.8 | 79.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
8.7 | 78.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
8.6 | 266.4 | PID NOTCH PATHWAY | Notch signaling pathway |
8.5 | 16.9 | PID TRAIL PATHWAY | TRAIL signaling pathway |
8.4 | 75.6 | ST GA13 PATHWAY | G alpha 13 Pathway |
8.4 | 167.7 | PID AURORA B PATHWAY | Aurora B signaling |
8.2 | 155.3 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
8.1 | 32.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
7.6 | 75.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
7.6 | 60.6 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
7.3 | 65.7 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
7.3 | 21.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
7.2 | 107.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
7.1 | 35.5 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
7.0 | 28.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
6.9 | 186.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
6.8 | 122.2 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
6.8 | 196.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
6.7 | 181.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
6.6 | 46.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
6.5 | 52.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
6.5 | 45.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
6.4 | 83.5 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
6.4 | 95.4 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
6.4 | 69.9 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
6.3 | 6.3 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
6.3 | 31.6 | PID FOXO PATHWAY | FoxO family signaling |
6.3 | 44.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
6.3 | 31.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
6.2 | 111.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
6.2 | 18.6 | PID SHP2 PATHWAY | SHP2 signaling |
6.1 | 24.4 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
6.0 | 119.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
5.7 | 45.7 | PID BCR 5PATHWAY | BCR signaling pathway |
5.7 | 22.8 | PID IL2 1PATHWAY | IL2-mediated signaling events |
5.7 | 56.8 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
5.6 | 101.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
5.5 | 104.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
5.2 | 20.9 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
5.2 | 5.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
5.2 | 46.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
5.1 | 35.6 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
4.9 | 9.7 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
4.8 | 19.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
4.6 | 602.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
4.5 | 72.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
4.3 | 30.3 | PID ATM PATHWAY | ATM pathway |
4.2 | 37.7 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
4.1 | 28.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
3.8 | 42.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
3.8 | 34.2 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
3.7 | 3.7 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
3.6 | 21.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
3.6 | 18.0 | PID ATR PATHWAY | ATR signaling pathway |
3.5 | 14.2 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
3.5 | 38.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
3.4 | 10.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
3.4 | 34.1 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
3.4 | 6.8 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
3.3 | 6.6 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
3.2 | 3.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
3.0 | 20.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
2.9 | 43.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
2.9 | 17.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
2.3 | 4.5 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
2.2 | 11.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
2.2 | 8.9 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
2.1 | 398.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
1.8 | 3.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
1.5 | 14.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
1.5 | 2.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
1.3 | 11.7 | PID BMP PATHWAY | BMP receptor signaling |
1.2 | 9.8 | PID IL23 PATHWAY | IL23-mediated signaling events |
1.1 | 43.3 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
1.0 | 6.0 | PID INSULIN PATHWAY | Insulin Pathway |
0.8 | 2.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.8 | 4.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.7 | 133.5 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.7 | 5.3 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.6 | 3.0 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.3 | 10.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.3 | 2.2 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 0.9 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
45.5 | 45.5 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
42.1 | 210.4 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
39.2 | 352.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
31.0 | 31.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
30.3 | 454.7 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
30.2 | 271.7 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
28.9 | 231.4 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
28.4 | 539.7 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
27.1 | 649.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
25.8 | 77.4 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
25.3 | 227.7 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
24.8 | 397.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
24.6 | 393.7 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
24.6 | 196.7 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
24.1 | 144.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
23.6 | 189.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
23.5 | 682.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
23.5 | 258.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
22.8 | 91.0 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
22.7 | 113.5 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
22.7 | 317.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
22.6 | 271.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
22.0 | 439.6 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
21.8 | 349.0 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
21.6 | 216.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
21.6 | 388.9 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
21.1 | 231.9 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
21.0 | 84.0 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
20.7 | 373.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
20.5 | 328.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
20.1 | 220.8 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
20.1 | 120.4 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
19.9 | 19.9 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
19.8 | 158.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
19.8 | 256.8 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
19.4 | 174.6 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
19.1 | 38.2 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
18.8 | 206.5 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
18.6 | 278.4 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
18.4 | 184.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
18.1 | 126.8 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
17.7 | 195.0 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
17.7 | 176.7 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
17.2 | 103.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
17.1 | 273.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
16.9 | 169.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
16.5 | 396.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
16.4 | 147.9 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
16.4 | 310.9 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
16.2 | 357.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
15.7 | 141.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
15.7 | 1396.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
15.7 | 31.3 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
15.5 | 77.7 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
15.5 | 540.9 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
15.3 | 229.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
15.3 | 152.8 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
15.2 | 410.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
15.2 | 212.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
15.2 | 91.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
15.2 | 166.8 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
15.1 | 150.7 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
14.6 | 72.9 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
14.5 | 275.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
14.4 | 28.8 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
14.3 | 185.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
14.2 | 14.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
14.2 | 14.2 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
14.1 | 14.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
13.8 | 481.5 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
13.6 | 176.7 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
13.5 | 338.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
13.5 | 81.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
13.5 | 26.9 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
13.4 | 846.7 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
13.4 | 80.4 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
13.3 | 239.0 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
13.2 | 185.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
13.2 | 394.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
13.0 | 78.0 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
12.9 | 90.3 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
12.7 | 278.9 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
12.6 | 12.6 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
12.4 | 74.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
12.3 | 209.6 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
12.3 | 36.8 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
12.1 | 12.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
12.1 | 12.1 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
12.1 | 133.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
12.1 | 289.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
12.0 | 300.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
12.0 | 216.1 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
11.9 | 478.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
11.9 | 59.6 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
11.9 | 427.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
11.9 | 237.4 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
11.8 | 23.5 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
11.6 | 174.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
11.6 | 150.4 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
11.3 | 351.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
11.1 | 78.0 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
11.0 | 77.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
11.0 | 76.8 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
10.9 | 610.6 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
10.7 | 10.7 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
10.7 | 106.7 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
10.7 | 202.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
10.5 | 52.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
10.5 | 10.5 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
10.4 | 10.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
10.3 | 10.3 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
10.2 | 285.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
10.1 | 160.9 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
10.0 | 170.5 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
9.9 | 228.5 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
9.8 | 167.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
9.8 | 39.2 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
9.8 | 88.0 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
9.6 | 849.0 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
9.6 | 105.9 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
9.6 | 67.1 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
9.6 | 124.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
9.4 | 28.1 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
9.3 | 92.9 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
9.3 | 176.2 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
9.2 | 55.3 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
9.2 | 18.3 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
9.1 | 73.0 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
9.1 | 27.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
9.1 | 90.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
9.0 | 18.1 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
9.0 | 360.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
9.0 | 27.0 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
8.9 | 142.5 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
8.9 | 88.9 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
8.9 | 17.7 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
8.7 | 130.4 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
8.6 | 250.4 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
8.6 | 86.0 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
8.6 | 94.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
8.6 | 171.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
8.4 | 67.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
8.4 | 8.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
8.3 | 283.6 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
8.3 | 124.6 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
8.3 | 57.8 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
8.2 | 122.9 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
8.2 | 302.7 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
8.2 | 73.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
8.0 | 96.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
7.9 | 1212.8 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
7.9 | 134.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
7.9 | 94.5 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
7.8 | 125.5 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
7.8 | 132.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
7.8 | 116.7 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
7.8 | 325.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
7.7 | 207.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
7.6 | 68.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
7.6 | 356.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
7.5 | 195.9 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
7.5 | 104.6 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
7.4 | 666.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
7.4 | 22.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
7.4 | 58.8 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
7.0 | 605.2 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
7.0 | 147.7 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
7.0 | 20.9 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
6.8 | 75.2 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
6.7 | 114.6 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
6.7 | 121.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
6.7 | 80.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
6.7 | 140.6 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
6.7 | 40.0 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
6.6 | 171.5 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
6.6 | 78.8 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
6.5 | 65.5 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
6.5 | 136.8 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
6.5 | 6.5 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
6.5 | 19.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
6.3 | 107.4 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
6.3 | 68.8 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
6.1 | 171.4 | REACTOME TRANSLATION | Genes involved in Translation |
6.1 | 134.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
6.1 | 72.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
6.0 | 108.0 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
6.0 | 53.7 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
6.0 | 17.9 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
5.9 | 47.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
5.9 | 29.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
5.8 | 58.2 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
5.8 | 52.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
5.8 | 75.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
5.8 | 28.8 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
5.6 | 163.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
5.5 | 66.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
5.5 | 27.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
5.5 | 71.5 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
5.5 | 240.6 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
5.4 | 69.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
5.4 | 37.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
5.3 | 42.6 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
5.3 | 37.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
5.2 | 5.2 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
5.2 | 88.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
5.1 | 25.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
5.1 | 81.6 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
5.1 | 25.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
5.0 | 20.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
5.0 | 24.8 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
5.0 | 34.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
5.0 | 64.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
5.0 | 138.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
4.9 | 4.9 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
4.9 | 34.1 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
4.8 | 9.7 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
4.8 | 71.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
4.7 | 23.7 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
4.7 | 14.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
4.7 | 9.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
4.6 | 274.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
4.4 | 104.7 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
4.3 | 156.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
4.2 | 29.6 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
4.2 | 37.9 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
4.2 | 8.4 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
4.2 | 20.8 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
4.0 | 4.0 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
4.0 | 87.2 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
4.0 | 7.9 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
3.9 | 244.1 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
3.8 | 3.8 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
3.8 | 52.6 | REACTOME MEIOSIS | Genes involved in Meiosis |
3.7 | 63.0 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
3.7 | 3.7 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
3.6 | 14.5 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
3.5 | 10.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
3.4 | 44.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
3.3 | 13.3 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
3.3 | 23.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
3.3 | 16.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
3.2 | 35.5 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
3.2 | 9.5 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
3.2 | 15.9 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
3.1 | 34.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
3.1 | 6.1 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
3.0 | 18.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
3.0 | 20.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
2.9 | 11.8 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
2.8 | 11.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
2.7 | 29.9 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
2.7 | 24.0 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
2.6 | 23.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
2.5 | 7.6 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
2.3 | 18.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
2.1 | 14.7 | REACTOME APOPTOSIS | Genes involved in Apoptosis |
2.0 | 2.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
1.9 | 15.3 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
1.8 | 74.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
1.7 | 26.1 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
1.7 | 99.7 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
1.6 | 18.0 | REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION | Genes involved in Post-translational protein modification |
1.6 | 30.7 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
1.6 | 1.6 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
1.6 | 3.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
1.5 | 27.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
1.4 | 8.4 | REACTOME MEMBRANE TRAFFICKING | Genes involved in Membrane Trafficking |
1.4 | 25.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
1.2 | 58.9 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
1.1 | 5.5 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
1.1 | 11.9 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
1.1 | 15.1 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
1.1 | 4.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
1.0 | 96.4 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.7 | 3.7 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.7 | 61.1 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.6 | 17.1 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.5 | 5.4 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.4 | 5.0 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.3 | 1.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.3 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.1 | 4.0 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.1 | 0.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |